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“Anyone who is not confused about oxidative phosphorylation 
 just doesn’t understand the situation” 
Efraim Racker 
  
ABSTRACT 
Regular physical activity is highly associated with many health benefits and regular exercise 
training is used in the prevention and treatment of a large number of disease conditions, 
including type 2 diabetes, cardiovascular disease and cancer. One of the key adaptations to 
regular exercise training is mitochondrial biogenesis and improved oxidative capacity, 
particularly in skeletal muscle tissue. There is an inverse relationship between the dose of 
regular physical activity and the risk for premature death and this might in part be explained 
by the mitochondrially related improvement of metabolic health in trained skeletal muscle. In 
contrast, low whole body aerobic capacity and muscle mitochondrial content are 
characteristics of a sedentary lifestyle that contribute to the development of metabolic disease 
and other disorders. Most tissues adapt to exercise training, not least skeletal muscle, which is 
a highly plastic tissue. Cellular adaptations in skeletal muscle are driven by extra- and 
intracellular signals arising from the exercise stimulus, e.g. changes in shear stress, oxygen 
tension, energy levels, pH and temperature. Ultimately, these cellular perturbations lead to 
gene expression and protein alterations that improve skeletal muscle, e.g. through enhanced 
mitochondrial function.  
The results in this thesis are based on skeletal muscle biopsies from the m.vastus lateralis, 
taken at rest (all studies) and at 30 min (study 2 and 3), 2hrs , 6hrs and 24 hrs (study 3) after 
an acute bout of exercise or after three months of training (study 4). The study subjects in 
Studies 1-3 were young healthy normally active individuals while in study 4 older men with 
impaired glucose regulation was recruited. Four different experimental models were used in 
this thesis; first, a one-legged knee extension exercise model with or without restricted blood 
flow in the leg; second, an acute bout of 60 min cycling; third, an acute bout of 60 min 
cycling (humans) or 36-40 min running on a treadmill (mice) or a 12-weeks high fat diet 
intervention (mice); and last a 12-week intervention in which resistance training or Nordic 
walking was performed.  
The main focus of this thesis was on the transcriptional coactivator PGC-1α and its upstream 
and downstream targets, coactivators and corepressors and how all these are affected by 
exercise. In Paper I, we show for the first time that PGC-1α can be transcribed from an 
alternative promotor in human skeletal muscle and that the PGC-1α-ex1b transcript seems 
like the most avidly exercise-induced transcript. In brief, an acute exercise bout with 
restricted blood flow massively increased the mRNA levels of the human skeletal muscle 
PGC-1α splice variant 2 hours after exercise, most likely mediated through activation of an 
alternative promoter. Protein data supported previous studies demonstrating the importance of 
AMPK activation in exercise-induced expression of PGC-1α mRNA. In paper III, twenty-two 
mRNA transcripts and five proteins were measured over a 24 h time-course. Interestingly, as 
a response to exercise the protein levels of PGC-1α-ex1b increased before the elevation of the 
Total PGC-1α protein which might indicate its importance in the early adaptation processes. 
We also demonstrated for the first time the existence and post-exercise expression pattern of 
two LIPIN-1 (LIPIN-1α and LIPIN-1β) and three NCoR1 (NCoR1-1, NCoR1-2, and NCoR1-
3) isoforms in human skeletal muscle. And just as in Paper I the data emphasized PGC-1α-
ex1b as the most exercise-responsive PGC-1α isoform. In Paper II, the investigation aimed to 
define a functional role for BRCA1 in skeletal muscle using a translational approach. For the 
first time, BRCA1 and two shorter isoforms were identified in both humans and mouse 
skeletal muscle. In response to exercise, an increased interaction between BRCA1 and ACC-
p was seen in both humans and mice. Decreasing the content of BRCA1 in primary human 
myotubes resulted in decreased oxygen consumption by the mitochondria and increased 
reactive oxygen species production. The decreased BRCA1 content also resulted in increased 
storage of intracellular lipids and reduced insulin signaling in human myotubes. These results 
indicate that BRCA1 might play a critical role in the regulation of metabolic function in 
skeletal muscle and address BRCA1 as a novel target to study further to pursue metabolic 
diseases. Lastly, Paper IV shows for the first time that protein levels of the mitochondrially 
encoded and derived peptide humanin increases after 12-weeks of regular resistance exercise. 
This very small peptide has been implied to have multiple functions including 
neuroprotective effect and a positive effect on glucose metabolism and oxidative stress.  
Preliminary data from the same study material also revealed that MOTS-c, another small 
mitochondrially derived and encoded peptide, from the 12S rRNA gene, also seems to be 
affected by resistance training. These mitochondrially encoded peptides are interesting target 
to study further in the attempt to understand, and in the future to optimize, retrograde 
signaling and maybe use them to treat diseases in which mitochondrial function is impaired, 
e.g. type 2 diabetes, Alzheimer’s disease and cancer.  
In conclusion, regular endurance training increases mitochondrial density through a complex 
network of transcriptional regulators that in an accumulated way are affected by each single 
exercise bout, and therefore is acute exercise also important to study in the endeavor to 
comprehend mitochondrial adaptations. Thus, it is important from a clinical, as well as basic 
science perspective to understand the regulation of skeletal muscle gene activity and the 
adaptation process at a molecular level in an attempt to recognize how it might contribute to 
the many health benefits seen with a physically active lifestyle.  
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THESIS AT A GLANCE 
Paper Aim Results Conclusion 
 
 
I 
 
To explore acute 
exercise- induced 
expression of PGC-
1a and its different 
transcripts. 
 
 
PGC-1a-ex1a and PGC-1a-ex1b 
increase in gene expression with 
exercise . 
AICAR and Norepinephrine 
increased expression of PGC-
1a-ex1a and PGC-1a-ex1b. 
 
 
PGC-1a-ex1a and PGC-1a-ex1b 
transcribed from alternative 
promoters are present and 
change with acute exercise. 
AMPK seem like a potential 
activator and PGC-1a-ex1b like 
the most exercise-responsive 
transcript. 
   
To examine and 
explore the presence 
and function of 
BRCA1 in skeletal 
muscle and its 
response to acute 
exercise. 
 
BRCA1 total and the two shorter 
isoforms, BRCA1∆11, 
BRCA1∆11b, are present in both 
human and mice skeletal 
muscle. Exercise increases the 
interaction between BRCA1 and 
ACC-p. Silencing BRCA1 
impaired fat oxidation, glucose 
uptake and mitochondrial 
function. 
 
 
BRCA1 is an important regulator 
of skeletal muscle metabolism 
and exercise seems to stimulate 
its action. 
 
 
 
III 
 
To investigate if PGC-
1a and its different 
transcripts and 
regulatory factors are 
regulated over a 24 
hour time course. 
 
PGC-1a-ex1b gene and protein 
expresson are highly and rapidly 
affected by exercise. 
 
 
The results from the study 
indicate that PGC-1a-ex1b is the 
most exercise-responsive PGC-
1a isoform. 
 
 
 
VI 
 
To study the 
mitochondrially 
encoded peptide 
humanin after 12 
weeks of training in 
men with impaired 
glucose regulation. 
 
 
Humanin increases with 
resistance training in skeletal 
muscle homogenate but not in 
serum. 
 
 
Humanin levels incresase with 
regular resistance training in 
prediabetic males and sems to 
have a role in glucose 
metabolism.  
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1 BACKGROUND  
1.1 PHYSICAL ACTIVITY AND HEALTH 
1.1.1 The benefits of exercise 
Movement and physical activity has always been a natural part of human life and physiology. 
Historically, the ability to perform physical activity was essential for survival. The connection 
between regular physical activity, endurance capacity and health was documented as early as  
3 000-2 500 BC in China and India (MacAuley 1994; Tipton 2014).  
Since the middle of the 20th century, a growing body of research has investigated the 
influence of regular physical activity on some of the most common diseases such as type 2 
diabetes, cardiovascular disease and Alzheimer’s disease (Morris et al. 1953; Warburton et al. 
2006; Booth & Roberts 2008; Booth et al. 2012). Even though we now know much about the 
very strong positive effects of exercise, physical inactivity, obesity and metabolic diseases are 
becoming much more common. They contribute to a severe and increasing burden of so-
called non-communicable disease (NCD) globally impacting individuals and society. Regular 
physical activity has many well documented salutary effects on health and performance, such 
as improved cardiovascular function, improved oxidative capacity, increased insulin 
sensitivity and improved quality of life (Holloszy & Booth 1976; Booth & Roberts 2008; 
Chimen et al. 2011; Russell et al. 2014). There is a strong inverse relation between total 
dosage (frequency, intensity and duration) of regular physical activity and risk for overall 
morbidity (Byberg et al. 2009; Blair 2009; Barry et al. 2014; Bouchard et al. 2015). Also, 
endurance training positively influences for example the endocrine system (Henriksson 
1995), the nervous system (van Praag 2009; Gallaway et al. 2017), and even promotes a 
better mental health (Fox 1999) as well as attenuates aging of the skin (Crane et al. 2015). In 
summary, physical activity influences the whole body, from the inside to the outside in 
beneficial ways.  
Advancing technologies such as the use of transgenic models, whole genome sequencing, 
transcriptomics and bioinformatics have been introduced. They have led to the identification 
of genes and their corresponding proteins which are affected by physical activity and also 
genes involved in different diseases (Baralle & Buratti 2017; Kienzler et al. 2017). Studies 
have shown that obesity and type 2 diabetes are associated to a dysfunction of skeletal muscle 
mitochondria (Mazat et al. 2001; Kelley et al. 2002; Patti et al. 2003; Chanseaume et al. 
2006; Chanséaume et al. 2007). Also, genes involved in mitochondrial oxidative 
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phosphorylation are less expressed in muscle of insulin-resistant patients suffering from 
obesity or type 2 diabetes (Simoneau & Kelley 1997; Kelley et al. 2002; Patti et al. 2003; 
Petersen et al. 2004; Ritov et al. 2005; Petersen et al. 2005). Despite that hundreds of papers 
have been published on mitochondrial biogenesis, it may represent only the tip of the iceberg 
regarding the biology of the mitochondrion, its oxidative capacity and the relationship to 
metabolic regulation. 
	
1.1.2 Metabolic dysregulation 
Our modern societies are facing a large global increase in metabolic disorders, linked largely 
to inactivity, inappropriate nutritional and other lifestyle habits as well as genetic 
predisposition. Metabolic dysregulation is by definition an impairment of a physiological 
regulatory mechanism. In this thesis, men with impaired glucose regulation (IGR) were 
studied before and after a training intervention. People  with IGR, as defined by the American 
diabetes association, are individuals having impaired glucose tolerance (IGT) and/or impaired 
fasting glucose (IFG) which can collectively be termed prediabetes (Anon 1997; American 
Diabetes Association 2010). 
Factors such as inactivity and obesity are often the initial triggers for the dysregulation and 
metabolic disorders, usually characterized by high levels of triglycerides and low levels of  
serum high-density lipoprotein (HDL) (Desvergne et al. 2006). Glucose levels in the blood in 
the postprandial period or upon fasting are normal at an early stage of metabolic 
dysregulation, reflecting a good b-cell function. If the dysregulation progresses, IGT, are 
usually diagnosed. This is characterized by an increased postprandial hyperglycemia and 
insulinemia (Desvergne et al. 2006). Type 2 diabetes mellitus (T2DM) occur as one of the 
later stages in this disease progression. All these different stages of metabolic dysfunctions 
are responsive to lifestyle changes and/or pharmacological treatment aiming to control 
glucose levels, insulin resistance, dyslipidemia, and the vascular complications. 
As mentioned in section 1.1, there are tremendous benefits of being regularly physically 
active, not least when it comes to prevent and treat a metabolic dysregulation and T2DM 
(Eriksson & Lindgärde 1998; Tabák et al. 2012; Bansal 2015; Koh 2016; Hesselink et al. 
2016). Exercise training improves glucose tolerance and insulin action in persons with IGR, 
as well as in T2DM (Rogers et al. 1988; Hughes et al. 1993). Substantial evidence suggest 
that the molecular mechanism for enhanced glucose uptake in the skeletal muscle with 
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exercise training may be due to increased expression and activity of key proteins coupled to 
metabolic signaling (Zierath 2002; Desvergne et al. 2006; Colberg et al. 2010). It is well 
established that dysfunctional glucose handling seldom comes without impairment in fat 
oxidation, and therefore it is important to study both of these metabolic pathways when 
evaluating  prediabetes patients (Randle et al. 1963).   
 
1.2 SKELETAL MUSCLE  
Skeletal muscle tissue constitutes between 40 and 50 % of total body mass, making it the 
largest organ in the body. Skeletal muscle can be seen as a multifaceted organ. Besides 
enabling locomotion, it is also a highly metabolically active tissue involved in the regulation 
of nutrients such as glucose and electrolytes e.g. potassium and calcium, and also serves as a 
protein reservoir (Fitts et al. 1975; Holloszy & Booth 1976). Skeletal muscle is the primary 
target for insulin-dependent and non-dependent glucose uptake, and accounts for up to 80 % 
of glucose disposal under insulin-stimulated conditions, with marked impact on glucose 
homeostasis (Defronzo et al. 1981; E. A. Richter & Hargreaves 2013). Additionally, skeletal 
muscle is the largest glycogen storage organ, with almost a 4-fold higher capacity than that of 
the liver (Mikines et al. 1988; Koopman et al. 2006).  
Within this multifaceted capacity, skeletal muscle is also suggested to act as a regulatory 
endocrine organ, contributing with its own secretome (Weigert et al. 2014; Karstoft & B. K. 
Pedersen 2016). The secretome of the muscle consists of several hundred peptides (called 
myokines) that may be involved in communication between skeletal muscle and other tissues 
such as adipose tissue, liver, pancreas, bone, and the brain (L. Pedersen & Hojman 2012; 
Benatti & B. K. Pedersen 2015; Karstoft & B. K. Pedersen 2016). It is possible that myokines 
in part mediate the preventative effects of exercise against chronic diseases, such as T2DM, 
cardiovascular diseases, cancer, and dementia. Interestingly, myokines have been implicated 
in mediating the paradigm of exercise as medicine (B. K. Pedersen & Saltin 2015). By 
combining experimental and bioinformatics approaches is was recently shown that insulin-
resistant skeletal muscle cells contained over 1000 putative secretable proteins, including 
some growth factors and cytokines. Important from a clinical perspective is that 
approximately 40 % of the secretable proteins found in these skeletal muscle cells were 
regulated under insulin-resistant conditions (Deshmukh et al. 2015). 
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It is commonly accepted that metabolic regulation in the skeletal muscle of complex 
organisms usually relies on different types of control systems. This control systems includes 
binding of an activator to a target, posttranslational modifications, protein-protein interactions 
and  transcriptional regulation (Desvergne et al. 2006). This thesis touches upon some of 
these regulatory mechanisms in skeletal muscle in response to physical activity and in 
metabolic dysfunctional stages.  
 
1.2.1 Skeletal muscle structure and plasticity 
Human skeletal muscle fibers are long, large and multinucleated cells that are highly 
organized into fiber bundles. Skeletal muscle fibers (cells) differ considerably in their 
metabolic profile (oxidative and glycolytic enzyme capacity), contractile speed and 
fatiguability, reflecting their ability to adapt to and cope to different demands and lifestyles. 
The dominating system for classifying human skeletal muscle fibers is based on isoforms of 
the myosin heavy chain (MHC) (Essén et al. 1975; Spangenburg & Booth 2003). In humans, 
there are three different types of skeletal muscle fibers namely type I, type IIa and type IIx. 
The type I fibers are slow-twitch oxidative fibers that can produce force over a long 
time/duration. Both type IIa and IIx are fast-twitch, glycolytic fibers that have high specific 
force production but low endurance capacity (Bárány 1967; Essén et al. 1975; Spangenburg 
& Booth 2003). With increasing contractile force, the recruitment of type IIa is prioritized 
before the type IIx (Egan & Zierath 2013). Skeletal muscle can be seen as a Russian doll, 
with layers and layers of smaller units that make up the full functional unit (see Fig. 1). 
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Figure 1. Schematic illustration of human skeletal muscle structure. Each muscle contains several 
bundles of individual skeletal muscle cells (fibers). The individual muscle fibers are surrounded by 
capillaries (dark red). An organized pattern of contractile myofibrils can be found inside the fibers, 
along with ATP-producing mitochondria (light blue), several nuclei and the Ca2+-containing 
sarcoplasmic reticulum (yellow). Illustration: Mattias Karlén 
Each skeletal muscle fiber contains multiple myofibrils, in which the sarcomere, the smallest 
and highly organized contractile unit is located. The fibers are arranged in parallel to each 
other and organized in bundles surrounded by connective tissue (the fascia). Each sarcomere 
contains the two main myofilaments, the proteins actin and myosin. By sliding against each 
other, and by the action of the cross-bridges, the myofilaments ultimately produce the 
mechanical force that contracts the muscle. The myofiber is surrounded by the sarcoplasmic 
reticulum that stores Ca2+ for release upon activation of the muscle. Ca2+ is the key that 
unlocks the contractile proteins and thus initiates the contractile process. In brief, Ca2+ makes 
the muscle contract and then relax in coordination with the provision of adenosine 
triphosphate (ATP). Going from rest to full activity can induce a 20-fold increase in whole-
body metabolic rate (Hale 2008; Egan & Zierath 2013) and increase energy demand >100-
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fold within the skeletal (Gaitanos et al. 1993). The final release of chemical energy to 
virtually all biological processes in human cells and those in all other living organisms is the 
ATP molecule which is broken down in to ADP (adenosine diphosphate) and free phosphate. 
During short and intense exercise, the first source of energy for contraction comes directly 
from stored ATP being hydrolyzed. Concurrently, chemical energy from creatine phosphate 
is transferred to form new ATP molecules. For work performed up to 90 seconds, anaerobic 
lactate formation provides most of the ATP needed. Over longer periods of work, ATP is 
primarily produced by oxidative phosphorylation in the mitochondria, which are highly 
abundant in skeletal muscle fibers, especially in type I fibers (the oxidative fibers). The body 
uses as much ATP in kilo gram as your body weight over a day (Törnroth-Horsefield & 
Neutze 2008) which means that the recycling rate is highly efficient. To produce ATP 
through aerobic metabolism, the muscle needs oxygen and nutrients (glucose and fatty acids) 
supplied via a network of capillaries interspersed in the fiber bundles (Windhorst & 
Mommaerts 1996). 
 
1.2.2 Response to physical activity 
Skeletal muscle is highly adaptable and responds to various external and internal stimuli such 
as exercise. Both acutely and over time, skeletal muscle demonstrates remarkable plasticity in 
structural and functional modifications and remodels itself in response to contractile activity 
and increased load. Metabolic adaptations in the different types of skeletal fibers, improved 
metabolic and mitochondrial functions as well as increased mitochondrial density and 
angiogenesis are some of the changes that occur in the skeletal muscle in response to the 
increased energy and structural demands that regular exercise induce (Egan & Zierath 2013).  
Exercise disrupts the resting skeletal muscle homeostasis and is dependent on the exercise 
type performed (aerobic or anaerobic) and the type of contraction conducted (concentric, 
eccentric or isometric or combination thereof). This disruption leads to muscle adaptation, 
and the frequency, intensity and duration, i.e the dosage, of the exercise performed will also 
affect this process. The metabolic and molecular responses might differ dependent on the 
exercise types, and usually reflects a certain functional outcome (e.g. endurance versus 
hypertrophy phenotype) (Coffey et al. 2006; Coffey & Hawley 2007). Although both aerobic 
and resistance exercise can individually promote substantial health benefits, different effects 
are observed depending on the parameter of interest. Even though both types of exercise 
improve glucose control and lower resting blood pressure, aerobic exercise training more 
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effectively modifies cardiovascular risk factors and resistance exercise training more 
effectively increase basal metabolic rate, muscle mass, and physical function in the elderly 
(Booth & Thomason 1991). Importantly, a combination of aerobic and resistance training is 
more effective than either modality alone for reducing insulin resistance and functional 
limitations in patients with obesity or the metabolic syndrome (Davidson et al. 2009; Colberg 
et al. 2010).  
 
1.2.3 PGC-1a and exercise induced transcriptional regulation 
Peroxisome proliferator-activated receptor (PPAR)- g coactivator (PGC)-1a, (PGC-1a), is a 
transcription coactivator encoded from the PPARGC1A gene located in chromosome 4 and 
codes for a 798 amino acid protein (Liang & Ward 2006).  
Both acute and regular exercise have long been known to increase the gene expression and 
protein levels of PGC-1a both in skeletal muscle and in other metabolically active tissues 
such as brain, kidney and fat (Holloszy & Booth 1976; Baar et al. 2002; Norrbom et al. 
2004; Gibala et al. 2009; D. A. Hood 2009; Steiner et al. 2011; Norrbom et al. 2011; 
Gidlund et al. 2015). PGC-1a is a very multi-faceted protein when it comes to function and 
action, playing different roles depending on the demands and needs of the cell. PGC-1a have 
been labelled a “master regulator” of mitochondrial biogenesis and as an important factor 
controlling the transcriptional machinery in the cell in response to increased energy demands 
as seen by metabolic stress or exercise (Z. Wu et al. 1999; J. Lin et al. 2005). PGC-1a is a 
coactivator, that coordinates expression of numerous nuclear-encoded mitochondrial 
transcription factors which have been proposed to be vital for the regulation of mitochondrial 
biogenesis (Z. Wu et al. 1999; J. Lin et al. 2005), see Fig. 2 for illustration. Some of the 
regulatory functions of the PGC-1a protein appears to be mediated by its strong co-activation 
of the nuclear respiratory factors 1 (NRF-1). This co-activation has been shown to be 
involved in both regulation of mitochondrial biogenesis and fiber type determination in 
skeletal muscle (Virbasius & Scarpulla 1994).  
Other important factors are mitochondrial transcription factor A (TFAM), mitochondrial 
transcription factor B1 and B2 (TFB1M, TFB2M) and the nuclear respiratory factor 2 (NRF-
2). PGC-1a has been shown to induce vascular endothelial growth factor (VEGF) gene 
expression by coactivation with estrogen-related receptor-a (ERRa) (Arany et al. 2008). And 
coactivation of PGC-1a with NRF-1 and/or ERRa has also been shown to increase 
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transcriptional activity of genes coupled to oxidative phosphorylation such as succinate 
dehydrogenase (SDH), b-oxidation and replication of the mitochondrial mtDNA (Kelly & 
Scarpulla 2004; Scarpulla 2011).  
 
 
Figure 2. Schematic illustration of a human skeletal muscle cell and its nucleus showing factors 
involved in exercise-induced adaptations. During and following exercise, stimuli such as mechanical 
stretch, calcium signaling and AMP/ATP ratio are affected (displayed in the cytoplasm). Effects of 
exercise on transcriptional regulation are shown inside the nucleus. The box shows example of 
nuclear-encoded mitochondrial transcriptions factors that are activated by PGC-1a. Illustration: 
Mattias Karlén 
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Previous studies from our lab and others have shown that PGC-1α gene and protein 
expressions are highly induced by exercise (Pilegaard et al. 2003; Norrbom et al. 2004; 
Norrbom et al. 2011; Gidlund et al. 2015). The network that is activated by PGC-1α has been 
shown to be downregulated by the nuclear receptor interacting protein-1 (RIP140). Previous 
studies have shown a connection between RIP140 and PGC-1α such that transcription factors 
activated by PGC-1α, e.g. NRF-1, are repressed by RIP140 (Hallberg et al. 2008). Also, 
strengthening the tentative metabolic role of RIP140 is the fact that the absence of RIP140 
leads to resistance to diet-induced obesity, and increased glucose clearance and insulin 
sensitivity in mice (Powelka 2005; Parker et al. 2006). It has also been shown that RIP140 is 
present in muscle tissue in a fiber specific manner, and that high expression of RIP140 
suppresses the formation of oxidative fibers (Seth et al. 2007). Nevertheless, lower levels of 
RIP140 do not seem required for exercise mediated increase of skeletal muscle mitochondrial 
content and  the inhibition of metabolic target genes driven by RIP140 might be bypassed by 
exercise (M. S. Hood et al. 2011; Frier et al. 2011; Hoshino et al. 2011; Gidlund et al. 
2015).  
Taken together, PGC-1α coordinates a broad metabolic and transcriptional network 
regulating oxidative metabolism and insulin sensitivity. This is essentially the same metabolic 
program that is activated by exercise and has been shown to be down-regulated by sedentary 
lifestyles as well as obesity and T2DM (Benton et al. 2008). 
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1.2.4 Glucose metabolism and regulation 
The metabolic pathway of glucose breakdown in mammalian cells is called glycolysis, which 
is a chain reaction where gluoce-6-phosphate is broken down to two pyruvic acids. The net 
products produced in the glycolysis are two ATP molecules, two molecules of the reduced 
form of the nicotinamide adenine dinucleotide (NADH) and two H+. The pyruvic acids are 
transformed in to acetyl coenzyme A (acteyl-CoA) in the mitochondria. This molecule, 
Acetyl-CoA, is then used to produce the energy-rich compound (GTP), CO2, NADH and the 
reduced form of flavin adenine dinucleotide (FADH2) in the citrate acid cycle (tricarboxylic 
acid (TCA) cycle) in the mitochondrial matrix. NADH and FADH2 (usually referred to as 
electron carriers) are oxidized in the electron transport chain (ETC), a process also called 
oxidative phosphorylation that is located in the mitochondrial membranes (Ramaiah 1976).  
During exercise, the main substrates for skeletal muscle contraction comes from muscle 
glycogen and blood glucose (derived from liver glycogenolysis and gluconeogenesis) as well 
as from ingested carbohydrates. The regulation of muscle glycogenolysis during exercise is 
dependent on both intramuscular factors and hormonal stimulation of the enzyme glycogen 
phosphorylase. Insulin is a major regulator of glucose uptake and by binding to and 
phosphorylating the insulin receptor at the cellular surface, an intracellular cascade is 
activated that leads to glucose uptake into the skeletal muscle cell. This intracellular cascade 
includes the insulin receptor substrate 1 (IRS-1) which binds to the phosphorylated tyrosine 
residues of the insulin receptor and is subsequently phosphorylated by the tyrosine kinase of 
the insulin receptor. Binding of IRS-1 to the p85 subunit of phosphatidylinositol 3-kinase 
(PI3-K) results in activation of a PI3-K-dependent pathway comprising phosphoinositide-
dependent kinase (PDK) and protein kinase C (PKC) (Röhling et al. 2016). Key downstream 
molecules modulate translocation of glucose transporter type 4 (GLUT4) to the plasma 
membrane and comprise, besides Akt/protein kinase B (Akt/PKB), also Ras-related C3 
botulinum toxin substrate 1 (Rac1), the TBC1 domain family member 1 (TBC1D1), or the 
Akt substrate of 160 kDa (AS160) (Röhling et al. 2016). However, skeletal muscle 
contraction by itself has been shown to translocate GLUT4 in an insulin-independent manner 
(Hayashi et al. 1997). The clearance of glucose due to muscle contraction has been shown to 
be a more potent stimulus than maximal insulin-stimulation (James et al. 1985). 
The glucose uptake in skeletal muscle during exercise occurs by facilitated diffusion. Glucose 
uptake is affected by the amount of glucose delivered, the sarcolemmal glucose transport and 
the intracellular clearance of glucose. During exercise bouts the glucose uptake by the 
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skeletal muscle can increase up to 50-fold (Sylow et al. 2017). This insulin-independent 
glucose uptake have been shown to involve regulatory factors such as the activation of the 
AMP-dependent protein kinase (AMPK), increased sarcoplasmic Ca2+ that may involve Ca2+-
calmodulin-dependent protein kinase (CaMK) and PKC, nitric oxide (NO), and reactive 
oxygen species (ROS) (E. A. Richter & Hargreaves 2013). Redistribution of the blood flow 
to working skeletal muscles during exercise enhances glucose delivery to, and glucose uptake 
by, the contracting skeletal muscle. Increased plasma glucose levels, e.g. following 
carbohydrate ingestion, has been shown to increase muscle glucose uptake during exercise 
(McConell et al. 2000). During exercise and contraction, GLUT4 is translocated very rapidly 
to the cell membrane and cannot be seen as a limiting factor for muscle glucose uptake. 
Increased exercise intensities also increase the glucose uptake in an intensity- and duration 
dependent manner (E. A. Richter & Hargreaves 2013). As a response of the muscle 
contraction, activation of the glycolytic and oxidative pathways within the muscle leads to 
increased glucose metabolism and maintained low intracellular glucose concentration as well 
as ATP production.  Exercise training can increase the efficiency of the skeletal muscle to 
metabolize glucose (translocation of GLUT4 and enzymatic upregulation, especially in the 
glycolysis) and is an essential component in the prevention and treatment strategy for 
glucose-related metabolic diseases such as T2DM. 
 
1.2.5 Fat metabolism and regulation 
The breakdown of fatty acid is called β-oxidation and occurs within the mitochondria. β-
oxidation is a process consisting of multiple steps by which fatty acids are broken down to 
acetyl-CoA and produces NADH and FADH2. As described above, acetyl-CoA is used in the 
citric acid cycle and NADH and FADH2 are mainly used in the ETC. Thus, to be able to enter 
the cell, fatty acids needs specific transporters. Fatty acid transporters include fatty acid 
translocase (FAT/CD36), tissue specific fatty acid transport proteins (FATPs), and plasma 
membrane bound fatty acid binding protein (FABP) (Lopaschuk et al. 2010; Holloway et al. 
2011). Once inside the cell, a CoA group is added to the fatty acid by fatty acyl-CoA synthase 
(FACS), forming long-chain acyl-CoA. To enter the mitochondria carnitine 
palmitoyltransferase 1 (CPT1) converts the long-chain acyl-CoA to long-chain acylcarnitine 
which allows the fatty acid to be transported across the inner mitochondrial membrane via 
carnitine translocase (CAT). This transport is a recycling process which exchange long-chain 
acylcarnitines for carnitine. Carnitine palmitoyltransferase 2 (CPT-2) located in the inner 
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mitochondrial membrane then converts the long-chain acylcarnitine back to long-chain acyl-
CoA, see Fig. 3. The long-chain acyl-CoA enters the fatty acid β-oxidation pathway, which 
results in the production of one acetyl-CoA from each cycle of fatty acid β-oxidation. If the 
fatty acid contain an odd number of carbons it is oxidized to one acetyl-CoA and one 
propionyl-CoA in the last cycle step of β-oxidation (Fukao et al. 2004).  
 
 
Figure 3. Schematic illustration of a human skeletal muscle cell and the action of the BRCA1 protein. 
The figure illustrates the nucleus (bottom right) and shows factors involved in transportation of fatty 
acids over the mitochondrial membranes (CPT-I and CPT-2). Retrograde signaling by humanin and 
MOTS-c is also displayed. Illustration: Mattias Karlén 
 
Fat oxidation contributes significantly to whole-body energy turnover both at rest and during 
submaximal exercise. During exercise and upon muscle contraction, FAT/CD36 moves to the 
plasma membrane and increases fatty acid uptake. An increased oxidation of fatty acids have 
been shown to delay the depletion of carbohydrates and will, therefore, improve endurance 
during prolonged exercise (Sahlin et al. 2008).  An efficient fat oxidation is not only of 
importance for exercise performance but also an health benefits in reducing the risk of 
developing metabolic diseases, as discussed in section 1.1. Acetyl-CoA carboxylase (ACC) is 
a central enzyme involved in fatty acid β-oxidation and fatty acid biosynthesis. ACC 
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catalyzes the carboxylation of acetyl-CoA producing malonyl-CoA (MaCoA). MaCoA 
inhibits mitochondrial fatty acid uptake by inhibiting the action of CPT1 (Lopaschuk et al. 
2010). The main pathway for the degradation of MaCoA is via malonyl CoA decarboxylase 
(MCD), which decarboxylates malonyl CoA to acetyl CoA and thereby hinder its inhibitory 
activity. 
Another way to modulate MaCoA activity has been suggested to involve the breast cancer 1 
early onset (BRCA1) protein. BRCA1 is a pleiotropic and estrogen-sensitive gene, mainly 
coupled to DNA repair and involved in tumor suppression. However, BRCA1 has also been 
shown to interact with the phosphorylated form of acetyl CoA carboxylase (ACC-p) and 
thereby decreasing the inhibitory action of MaCoA in human breast cancer cells (Magnard et 
al. 2002; Moreau et al. 2006).  
Fatty acid oxidation might also be regulated transcriptionally by factors regulating the 
expression of genes coding for proteins involved in fatty acid uptake and oxidation, as well as 
specific enzymes involved in the β-oxidation. Such transcriptional control is exerted by the 
relatively large family of nuclear receptors called PPARs (PPAR-a, PPAR-d, and PPAR-g) 
which are subject to transcriptional coactivation by PGC-1α (Lopaschuk et al. 2010).  Genes 
coding for e.g. FAT/CD36 and CPT1 have been shown to be regulated by PPAR-a (Yang & 
Li 2007). To summarize, the regulatory mechanism for fatty acid oxidation can occur in 
several different steps within the process. Numerous factors seem to affect the fatty acid 
oxidation, including e.g. exercise (in an intensity and duration dependent way), BRCA1 
through the interaction with ACC-p and PGC-1α by regulating transcription of genes 
important for β-oxidation and mitochondrial biogenesis. 
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1.3 THE MITOCHONDRIA 
1.3.1 The magic of the mitochondria 
Billion years ago, free-living aerobic bacteria (a prokaryote) managed to survive the 
endocytotic engulfment by a eukaryotic cell and a successful symbiosis was established. This 
is called the endosymbiotic theory which lead to one of the most enduring symbiotic 
relationships known in biology (Stewart & Chinnery 2015). This symbiotic relationship 
formed the organelle that we call the mitochondria and made the evolution of more complex 
multicellular organisms possible (Gray et al. 1999) .  
This symbiosis occurred around at the same time as oxygen tension in the earth’s atmosphere 
began to rise (Farquhar et al. 2000; E. O. L. Karlberg & Andersson 2003) which provided a 
survival benefit for the eukaryotic cell since an oxygen-dependent highly efficient metabolic 
system became available (Gray et al. 1999). This oxygen-dependent system in the 
mitochondria is essential for ATP production by oxidative phosphorylation. Without the 
fusion of the eukaryotic cell and these bacteria all living animals would be dependent on 
anaerobic glycolysis for ATP production. In addition, the mitochondria are abundantly 
present and vital for animal cells, and involved in lipid and amino acid metabolism and play 
important roles in various cellular processes such as cell proliferation, apoptosis and cell 
differentiation (M. Sato & K. Sato 2013). 
 
1.3.2 Function, structure and biogenesis 
1.3.2.1 The genome and proteome of the mitochondria 
Mitochondria are organelles surrounded by two membranes, the outer and the inner 
membrane. This membrane structure forms two separate aqueous compartments, the matrix 
and the intermembrane space (see Fig. 4). The cristae of the mitochondria are formed by 
tubular invaginations of the inner mitochondrial membrane, in which the enzyme complexes 
of the ETC are abundantly located and those providing the cell with energy in the form of 
ATP. Located within the matrix of the mitochondria the other metabolic systems involved in 
glucose and fatty acid breakdown, the TCA cycle and the b-oxidation, can be found 
(Falkenberg et al. 2007). 
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Figure 4. Illustrations of mitochondrial structure. Illustration: Mattias Karlén 
 
Even though the mitochondria are enclosed within a membrane and defined as a organelle, 
they should not be considered as a single entities, rather a network of interconnected 
membranes making up a tubular dynamic reticulum within the cell (Kirkwood et al. 1986; 
Sukhorukov et al. 2012). Fusion and fission dynamics are constant ongoing events of the 
mitochondria which leads to  branching of the reticulum of tubules (Sukhorukov et al. 2012). 
Mitochondria are unique organelles since they contain their own circular DNA 
(mitochondrial DNA, mtDNA). DNA of this cytoplasmic organelle, the mitochondria, is not 
inherited in a Mendelian manner. It is widely accepted that mtDNA is inherited maternally, 
solely from the mitochondria of the oocyte from which the animal develops (M. Sato & K. 
Sato 2013). Human mitochondria contain a compact circular, double-stranded molecule of 16 
569 bp (16.6 kbp) genome (see Fig. 5), with no known introns and very few non-coding 
nucleotides. Traditionally, the human mtDNA  has been considered to contains 37 genes, 
coding for two rRNAs, 22 tRNAs and 13 polypeptides (Falkenberg et al. 2007). The small 
size of the mtDNA limits its coding capacity and is thought only to account for a small 
fraction of the organelle's entire proteome, which consists of at least 1500 different proteins. 
The 13 proteins encoded by mammalian mtDNA are all components of the ETC. Different 
versions of the endosymbiotic theory have argued that there was a massive transfer of genes 
from the endosymbiont into the nuclear genome during the evolution of the mitochondrion. 
Indeed almost all of the genes encoding the proteins of modern mitochondria are found in the 
nuclear genomes of their host cell (O. Karlberg et al. 2000). Thus, the mitochondrial genomic 
machinery does not unaided control the organelle’s proteome. The remaining ~77 subunits 
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involved in the ETC are encoded by nuclear genes, as are all proteins required for the 
transcription, translation, modification, and assembly of the 13 mtDNA proteins (Calvo & 
Mootha 2010). However, this view has recently been somewhat challenged and previously 
unknown features of mitochondrial gene expression, function and regulation have been 
suggested which indicate that the mitochondrial transcriptome and proteome are far more 
complex than previously thought (Hashimoto, Ito, et al. 2001; Mercer et al. 2011).  
Nuclear genome insertions of mitochondrial origin known as NUMTs have also been 
identified (Bensasson et al. 2001; Ramos et al. 2011). In 1967 the first report of DNA 
fragments with homology to the mitochondrial genome was published (Buy & Riley 1967). 
Later, the nuclear mitochondrial pseudogenes arose as a concept. A possible explanation for 
these integrations of mtDNA is incorporation into the nuclear genome during the repair of 
chromosomal breaks by nonhomologous recombination. Such hypothesis, of a possible 
incorporation of mtDNA, is supported by the presence of mtDNA fragments in the nucleus 
(Bensasson et al. 2001; Mishmar et al. 2004). There are over 500 NUMTs in the human 
genome (Mishmar et al. 2004; Richly & Leister 2004). Even though most NUMTs are 
considered pseudogenes, bioinformatics based evidence suggests that at least some of the 
nuclear sequences might be functional genes (Bodzioch et al. 2009).  
To summarize, the mitochondria are unusual and vital organelles, surrounded by two 
membranes, contain its own circular DNA and make up a dynamic network which acts as the 
powerhouse of the cell.  
 
1.3.2.2 Transcription and replication of the mitochondrial DNA 
Contrary to the nuclear genome, mitochondria are continuously turned over and replicated 
independent of the cell cycle (Bogenhagen & Clayton 1977). The mitochondrial chromosome 
contains no introns. There is, however, a non-coding regulatory region known as the 
displacement loop (D-loop) in which the promoter for transcription of both the heavy strand 
(HS1) and the light strand (LS) are located (Montoya et al. 1982). Almost the entire heavy 
strand is transcribed from the other heavy strand (HS2) promoter (located in proximity to the 
D-loop) and the entire light strand is transcribed from the LS promoter (Stewart & Chinnery 
2015). The HS1 promoter initiate the transcription of the two mitochondrial rRNA molecules 
(Clayton 2000b; Stewart & Chinnery 2015), see Fig. 5.  
 28 
Transcription from the mitochondrial promoters results in polycistronic precursor RNA 
molecules, that are processed to yield individual mRNA, rRNA and tRNA molecules 
(Falkenberg et al. 2007). Replication and transcription of mtDNA are tightly coupled, with 
LS transcription producing RNA primers for mtDNA replication initiation (Clayton 2000b). 
Although the mitochondria are self-sufficient when it comes to the production of ribosomal 
subunits and tRNA molecules, enzymes and other factors required for transcription of 
mtDNA are nuclear-encoded and subsequently imported to the mitochondrial matrix. 
 
Figure 5. Schematic illustration of the mitochondrial DNA molecule. Shown are the heavy strand, the 
light strand, the light strand promoter (LSP), the heavy strand promoter 1 and 2 (HSP1, HSP2), the D-
loop as well as the origin of light strand replication site (OL) and the origin of heavy strand replication 
site (OH). Redrawn from the book - Abdul Aziz Mohamed Yusoff, F.A.Z.I.H.J. & Abdullah, J.M., 2015. 
”Understanding Mitochondrial DNA in Brain Tumorigenesis. In Molecular Considerations and 
Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor”. InTech. 
Illustration: Eva-karin Gidlund 
 
Precursors of nuclear-encoded mitochondrial proteins are transported over the mitochondrial 
membranes by specific transport complexes, the translocase of the outer membrane (TOM) 
and the translocase of the inner membrane (TIM) (Dudek et al. 2013). Mitochondrial 
transcription requires nuclear-encoded protein such as mitochondrial RNA polymerase 
(POLRMT) with assistance and co-activation of the mitochondrial transcription factors, 
TFAM, together with either TFB1M or TFB2M. The genes encoding TFB1M and TFB2M 
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are ubiquitously expressed with the highest mRNA levels detected in heart, skeletal muscle 
and liver and both TFB1M and TFB2M can form a heterodimeric complex with POLRMT 
(Asin-Cayuela & C. M. Gustafsson 2007). However, how the mammalian mitochondrial 
transcription machinery recognizes promoter sequences is not yet fully understood. POLRMT 
in complex with TFB1M or TFB2M cannot initiate transcription in the absence of TFAM. 
One possible role for TFAM might be to introduce specific structural alterations in mtDNA, 
for example, unwinding of the promoter region, which might facilitate transcription initiation 
(Asin-Cayuela & C. M. Gustafsson 2007; Sologub et al. 2009). TFAM have also been shown 
to be upregulated in expression by NRF-1, which coordinates nuclear encoded respiratory 
chain expression with mitochondria gene transcription and replication. Moreover, 
mitochondrial transcription termination factors (MTERFs) have also been described as a 
family of additional regulators displaying multiple roles in the regulation of  mitochondrial 
transcription (Roberti et al. 2009). 
Recently, TFAM has also been suggested to play a role in the replication and checkpoint 
system of mtDNA (Lyonnais et al. 2017). Replication of the mtDNA is necessary for 
maintenance of the organelle and for mitochondrial biogenesis to occur (Medeiros 2008). The 
replication of mtDNA, is also highly dependent on nuclear events. The proteins known to be 
of importance for this process are DNA polymerase γ (POLG), mitochondrial single-stranded 
DNA-binding protein (mtSSB) and the Twinkle helicase (also known as PEO1). The Twinkle 
helicase as the ability to unwind short segments of the mtDNA and thereby aiding the 
replication process (Wanrooij & Falkenberg 2010). Unlike nuclear DNA, which is packaged 
into nucleosomes, mtDNA molecules are tightly associated with the mitochondrial matrix and 
form compact structures called nucleoids, composed of mtDNA-protein complexes that 
include proteins involved in replication and transcription such as mtSSB, DNA POLG, and 
TFAM (Spelbrink 2010). The RNA primers used to initiate mtDNA synthesis at the origin of 
replication for the heavy strand (HS) called the OH site (also known as OriH), are generated 
from mitochondrial RNA (Clayton 2000a). Copying of the heavy strand later facilitates 
priming of replication of the origin of light strand replication site (OL). 
Two models of mtDNA replication have been proposed, the strand-displacement model and 
the symmetric strand-coupled replication (Shadel & Clayton 1997). Mammalian mtDNA 
molecules replicate by the strand-displacement model and replication is induced by 
transcription within the non-coding D-loop. In brief, the replication proceeds clockwise from 
the OH until the OL is exposed, allowing light strand synthesis to proceed clockwise until the 
entire molecule is copied.  
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When the mitochondrial replisome responsible for replication proceeds clockwise past the D-
loop region, two thirds of the growing HS is formed before a point is reached at which 
growing LS synthesis can start at OL circle (Clayton 2000a; Stewart & Chinnery 2015). As a 
newly exposed single-stranded template sequence in the HS forms a hairpin to constitute OL, 
HS replication (into an emerging LS) commences in the opposite direction. Both strands are 
thus replicated as leading strands (5'®3' directed) rather than lagging strands (Abdul Aziz 
Mohamed Yusoff & Abdullah 2015). The progeny molecules are released as dissimilar free 
circles. The new double-stranded mtDNA molecule is formed through the removal of the 
RNA primers, gap-filling, introduction of super-helical turns and closure of the circle 
(Clayton 2000a; Stewart & Chinnery 2015).  
In addition, POLRMT and the transcriptional machinery mentioned above also influences the 
replication process of mtDNA. POLRMT generates the RNA primers used to initiate leading-
strand mtDNA synthesis at the origin of heavy strand DNA replication (FustE et al. 2010). 
The transcription factor PGC-1α is also an important regulator of mitochondrial biogenesis by 
its strong co-activation of NRF-1. In turn, NRF-1 activates TFAM and TFB1M and TFB2M 
and thereby stimulates the cell to increase its mitochondrial copy number (Fisher et al. 1992; 
Falkenberg et al. 2002), which illustrates that mitochondrial replication and transcription are 
tightly linked (Holt & Reyes 2012). 
 In summary, the morphology and functional properties of mitochondria are, under a highly-
regulated fashion, finely tuned to meet changes in energetic, metabolic, and signaling 
demands of the skeletal muscle cell.  
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1.3.3 Retrograde signaling  
The symbiosis between the mitochondrion and the eukaryotic cell created the need for a 
communication system between mitochondria and the nucleus to coordinate mitochondrial 
protein synthesis during biogenesis and to communicate possible mitochondrial malfunctions. 
Communication from the mitochondria to the nucleus is referred to as retrograde signaling, 
and communication from the nucleus to the mitochondria is known as antegrade signaling (da 
Cunha et al. 2015). The mitochondria have traditionally been perceived as end-function 
organelles that receive cellular signals and regulate processes such as energy conversion and 
apoptosis in response to these signals. However, in recent years it has become evident that 
cellular homeostasis requires a constant and active flow of information between the 
mitochondria and the nucleus (C. Lee et al. 2013). The research has mainly been focused on 
a limited number of retrograde signaling molecules and signaling pathways such as sirtuins, 
cytochrome C, ROS, Ca2+, Fe2+, NO and CO (Verdin et al. 2010; Ganta & Alexander 2009; 
Ichikawa et al. 2012). It has also been shown that mtDNA itself can act as a retrograde signal 
in the inflammation response or by other cellular stress  (Nakahira et al. 2011; Saki & 
Prakash 2016). In addition to subcellular signaling programs, mitochondrial factors can even 
be released from one cell and exert paracrine or endocrine effects on a different cell, e.g. 
cellular stress can result in externalization of bits of mtDNA, and this circulating mtDNA 
have been shown to evoke a systemic inflammation response (Q. Zhang et al. 2010). Beyond 
these retrograde signals, recent studies have identified a host of mitochondria-linked factors 
that influence the cellular and extracellular environments, including mitochondria-derived 
peptides (MDP’s) and mitochondria-localized proteins (Battersby & U. Richter 2013; C. Lee 
et al. 2013; Kadlec et al. 2016). The first described mitochondria-derived peptide was 
humanin (HN) (Hashimoto, Niikura, et al. 2001), and more recently another small peptide 
also encoded from the mtDNA called MOTS-c was discovered (C. Lee et al. 2015), see Fig. 
3. Moreover, in 2013 transcriptional profiling identified over 70 different transcription factors 
that actively were involved in mitochondrial retrograde signaling and among those PGC-1α 
and hypoxia inducible factor (HIF-1) were presented as some of the main candidates 
affecting retrograde signaling pathways (Chae et al. 2013).  
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1.3.4 A gene within a gene 
In 2001, the mitochondrially-derived peptide humanin (HN) was identified from a cDNA 
library from the surviving neurons of human Alzheimer’s disease brain (Hashimoto, Niikura, 
et al. 2001). This 24-amino acid polypeptide was shown to be transcribed from a 75 bp open 
reading frame (ORF) of the 16S rRNA (MT-RNR2) gene within the mtDNA which makes it 
a gene-within-a gene. The term humanin was coined by its discoverer, Professor Nishimoto, 
to denote the potential of this molecule to restore the ‘humanity’ of patients with Alzheimer’s 
disease since HN previously was described as a neuroprotective and anti-apoptotic factor (C. 
Lee et al. 2013). Whether HN is translated in the mitochondrion or the cytoplasm is not fully 
known. Mitochondrial HN translation result in a slightly shorter peptide (21 amino acids) 
than that of cytoplasmic translation (24 amino acids) (Yamagishi et al. 2003; Bin Guo et al. 
2003). Both the HN peptide originating from the mitochondria and cytoplasm has been 
shown to be biologically active but the translational site in humans remains undetermined 
(Bin Guo et al. 2003; Sreekumar et al. 2016). HN has been shown to interact with the 
insulin-like growth factor binding protein 3 (IGFBP- 3) (Ikonen et al. 2003) and the pro-
apoptotic protein BAX (Bin Guo et al. 2003). HN could be an important link for 
understanding the role of the mitochondria beyond its central function as a cellular “power 
house”. The role and function of HN is complex and several other features have been coupled 
to HN activation, such as improved beta cell function and peripheral insulin signaling 
(Muzumdar et al. 2009). The HN analog HNGF6A has also been shown to increase glucose-
stimulated insulin secretion in both normal and diabetic mice (Kuliawat et al. 2013). 
Interestingly, HN levels in plasma have recently been demonstrated to be lower in patients 
with impaired fasting glucose compared to a control group (Voigt & Jelinek 2016). The 
involvement of HN in mitochondrial function was recently shown in human retinal pigment 
epithelial cells treated with HN in vitro, which displayed marked increase in mtDNA copy 
number and upregulated TFAM protein (Sreekumar et al. 2016). 
The initial discovery of HN spurred the search for more MDP’s and in 2015 a small 16-amino 
acid peptide encoded within an ORF (51 bp) of the 12S rRNA gene (MT-RNR1) called 
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c ) was discovered (C. Lee et 
al. 2015). MOTS-c has been shown to be important for glucose regulation by inhibiting the 
folate cycle and its tethered de novo purine biosynthesis, leading to AMPK activation in 
skeletal muscle. Also, levels of MOTS-c are reduced in obese people and patients with 
insulin resistance (C. Lee et al. 2015). Like a Russian nesting doll, HN and MOTS-c are 
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genes-within-a-gene, within an organelle within a cell, and the function of these MDP’s are 
still not fully understood.  
 
1.3.5 The mitochondria, impaired glucose regulation and T2DM  
Defects in mitochondrial function have been linked to many of the most common diseases of 
aging such as T2DM, Parkinson’s disease, atherosclerotic heart disease, stroke, Alzheimer’s 
disease, and cancer. Mitochondrial dysfunction has been associated with changes in mRNA 
levels of mitochondrial markers, alterations in protein levels or in enzymatic activity of key 
components of the mitochondrial oxidative machinery as well as changes in mitochondrial 
size, shape and substrate oxidation (Montgomery & Turner 2015). In brief, studies have 
shown that genes involved in the mitochondrial oxidative phosphorylation are down-
regulated in muscle of insulin-resistant patients suffering from obesity or T2DM (Kelley et al. 
2002; Patti et al. 2003; Ritov et al. 2005).  It has also been shown that obese people have a 
reduced whole-muscle mitochondrial content which has been suggested to be a result of 
impaired mitochondrial biogenesis (Kelley et al. 2002; Holloway 2009). However, human 
exercise studies have demonstrated a clear connection between exercise and  improvements 
in mitochondrial function in T2DM patients (Rimbert et al. 2004; Toledo et al. 2007; Phielix 
et al. 2010; Nielsen et al. 2010; Meex et al. 2010).  The action by which the mitochondria 
might be an important player in the restoration and prevention of IGR and T2DM seems to be 
connected to PGC-1α abundance and activity, and it also seems like this is the pathway 
activated by exercise (Patti et al. 2003; Mootha et al. 2003; Short et al. 2003). 
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2 AIMS 
Understanding fundamental molecular mechanisms behind skeletal muscle adaptations to 
exercise and regular physical activity has high scientific importance. Additionally, insights 
into such mechanisms can form the basis for preventing and treating metabolic and chronic 
diseases linked to physical inactivity, ageing and obesity. 
The overall aim of this thesis was to examine PGC-1a and its surrounding network and 
related regulatory factors important for skeletal muscle adaptation to physical activity. The 
main focus was to improve the understanding of the molecular mechanisms that contribute to 
mitochondrial adaptations both in healthy humans and in men with impaired glucose 
regulation.  
The specific aims of this thesis were to investigate; 
 
• if metabolic perturbation affects the PGC-1a transcripts in different ways (study 1). 
 
• if exercise increases the expression of the PGC-1a-ex1b isoform to a greater extent 
than that of PGC-1a-ex1a (study 1 and 3). 
 
• if BRCA1 is present in skeletal muscle and if so, whether it is involved in the 
regulation of metabolism in human and mouse skeletal muscle (study 2). 
 
• the effect of a single exercise bout on the levels of PGC-1a, its different transcripts 
and related regulatory factors over a 24-hour time course (study 3). 
 
• if 12 weeks of either resistance or endurance-type training in men with IGR changes 
the expression of the mitochondrially encoded peptide humanin (study 4). 
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3 METHODOLOGY 
3.1 SUBJECT CHARACTERIZATION AND INTERVENTION 
SUMMARY 
Table 1. Schematic summary of included studies, material, interventions and paper of this thesis. 
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3.2 EXPERIMENTAL MODELS AND TISSUE SAMPLING  
3.2.1 Skeletal muscle biopsies and blood sampling in humans 
Muscle biopsies, using the percutaneous muscle biopsy technique (Bergström 1962), were 
obtained from the m. vastus lateralis in all the human studies. Biopsies were taken before (all 
studies) and at different time points after either acute exercise or long-term training. Post 
biopsies were obtained at 0 min (Paper I), 30min (Papers II and III), 2h (Papers I and III), 
6 hrs (Paper III), 24 hrs after an acute bout (Paper III) and 48-72 hrs (Paper IV) after the 
last training session in a 12-week intervention. Prior to the biopsy, the skin was shaved and 
cleaned with alcohol. Local anesthetic (carbocain 10 mg/ml) was injected in the skin and 
down to the muscle fascia. An incision was made through the skin and fascia. The biopsy 
needle was inserted through the incision into the muscle and a small biopsy was cut out. The 
biopsy was then snap frozen in liquid nitrogen and stored for further analyses. If more than 
one biopsy was obtained from the same muscle, a new incision was made approximately 2-4 
cm proximal to the previous one. Blood samples were drawn after an overnight fast (12 h) 
from the brachial vein of all subjects before the intervention and after the 12-week 
intervention period (Paper IV). In this prolonged intervention study subjects were instructed 
to avoid alcohol, intensive exercise and analgesic for 2 days before sample collection. The 
amount of dietary carbohydrates was advised to match their normal consumption for 3 days 
before sample collection. Plasma, serum, and glucose tubes were centrifuged at 2200 g for 10 
min in room temperature, plasma and serum samples were stored in multiple portions at -80 
°C. Studies 1-3 was approved by the Regional Ethical Review Board in Stockholm, Sweden. 
All subjects gave their written informed consent before participating. The Ethic Committee of 
the Hospital District of Helsinki and Uusimaa in Finland approved the protocol of study 4 
and all the study subjects gave written informed consent. All studies in this thesis conformed 
to the standards set by the Declaration of Helsinki. The University of Maryland IACUC 
Review Board approved all aspects involving animals both in the exercise study and of the 
high fat diet study (study 2). 
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3.2.2 Skeletal muscle sampling in mice 
The University of Maryland Institutional Animal Care and Use Committee (IACUC) Review 
Board approved all aspects involving animal research. Male and female C57Bl/6 mice 
ranging from 8-10 weeks and 12-week-old male mice were utilized in Paper II. At the end of 
the exercise bout or after 10 weeks of a high fat diet (HFD) program, animals were 
euthanized and skeletal muscle (m. tibialis anterior, m. soleus, m. gastrocnemius (acute 
exercise study) and m. plantaris (HFD-study)) was harvested, weighted, snap frozen in liquid 
nitrogen, and stored at -80°C.  
 
3.2.3 Training with restricted blood flow (Paper I) 
Restricted blood flow has been shown to increase the energy demand and the intracellular 
exercise response within skeletal muscle cells, thereby mimicking extreme exercise intensity. 
In this study, twelve healthy men performed one-legged knee extension exercise using a 
pressure chamber model to induce blood flow restriction. This exercise model was first 
described back in 1987 (Eiken & Bjurstedt 1987) and further characterized by Sundberg and 
Kaijser (Sundberg & Kaijser 1992). External pressure over the working leg was used to 
restrict blood flow during exercise in a controlled fashion. The subjects mean (range) age, 
height, and weight were 24 (20-27) yrs, 181 (173-190) cm, and 75 (63-90) kg, respectively, 
and mean (range) maximal oxygen consumption (VO2max) was 51 (43-64) ml·kg-1·min-1. 
The subject was positioned supine in the opening of a large pressure chamber with both legs 
inside the chamber and one leg strapped to a pad. The pad was connected to a crank arm of an 
electrically braked cycle ergometer with locked flywheel. The chamber opening was sealed 
off at the level of the crotch by a rubber diaphragm. Shoulder supports were used to prevent 
craniad displacement of the body with increased chamber pressure. For the restricted (R) 
blood flow exercise, the chamber pressure was elevated to 50 mmHg above atmospheric 
pressure. This has been shown previously to restrict leg blood low during one-legged cycle 
exercise by 15-20 %, reduce oxygen saturation by 10-12 percentage units (Sundberg & 
Kaijser 1992) and cause a greater depletion of ATP, creatine phosphate as well as increase 
lactate concentrations in the exercising leg (Sundberg 1994). In this sense, this type of 
exercise mimics the cellular response seen during and after extremely intense exercise. 
Exercise with non-restricted (NR) blood flow was performed using the same experimental 
set-up but with normal atmospheric pressure. The exercise bout consisted of 45 min with 
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restricted blood flow to the working leg, followed by 45 min with normal blood flow to the 
other leg. The subjects were randomized regarding which leg they should exercise in the R-
condition. All subjects exercised the R-leg condition first, and were instructed to exercise at 
the highest tolerable workload for 45 min, taking into account that they must complete the 
entire session. After a short rest, exercise in the NR-leg condition was performed using the 
same workload profile as recorded for the R-leg condition but using normal atmospheric 
pressure. Accordingly, the two legs developed the same absolute power and amount of work 
in each session, although the ischemic training was perceived as much more strenuous. 
Muscle biopsies from the m. vastus lateralis of both legs were obtained using the 
percutaneous needle biopsy technique at rest before the exercise bout (R- and NR- condition) 
followed by post-exercise biopsies directly after and 2 hrs after exercise. The pre-biopsy in 
the NR-leg was performed at the same time as the 2 hrs post-biopsy in the R-leg. The subjects 
were resting between the biopsies. 
 
 
Figure 6. Schematic illustration of the experimental settings in study 1. One-legged knee-extension 
training performed in a pressure chamber. Modified from Ola Eiken (1987). 
  
of the session. To reduce the risk of circadian influences, all subjects began their 
participation around the same time of day. 
3.1.2   10-day training study (Paper I)
Ten healthy males with a VO2 max below 60 ml min-1 kg-1 were included in the 
study and performed one-legged knee extension exercise four times per week, 
over a 10-day period. It was hypothesised that metabolic perturbation in the form 
of restricted blood flow (ischaemic) exercise with ensuing tissue hypoxia could 
elicit  a stronger or different intracellular response in skeletal muscle than exercise 
under normal blood flow conditions. Hence, one leg was trained using local 
application of external pressure over the working leg to reduce blood flow (R-
leg), whilst the other leg was trained with non-restricted blood flow (NR-leg). A 
pressure chamber technique originally describ d by Eiken & Bjurstedt was 
emplo ed (Eiken & Bjurstedt, 1987) (Figure 5). To induc  ischaemia, t r ssure 
acting on the exercising leg was levat d to 50 mmHg above atmospheric 
pressure. This has been shown to reduce leg blood flow during one-legged cycling 
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Figure 5. Exercise set-up for lower body restriction of blood flow. The model allows 
modulation of pressure during one-legged knee extension exercise, facilitating a reduction of 
blood flow to the working leg. Modified from Eiken (1987).
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3.2.4 Acute exercise (Paper II and III)  
To gain insight into the temporal resolution of gene expression after a single exercise bout, an 
acute exercise study was performed. Twenty-seven healthy subjects were included in the 
study. Out of these, ten men and ten women were enrolled in Paper III and thirteen men and 
thirteen women in Paper II. Some subjects were overlapping between study 2 and 3. Their 
mean ± SD age, height, and weight, for men and women were; 26 ± 3.3 and 25 ± 2.9 yrs, 182 
± 6.2 and 169 ± 6.2 cm, and 81 ± 6.5 and 64 ± 6.5 kg in Paper II and 25 ± 2.7 and 24 ± 2.8 
yrs, 182 ± 4.8 and 169 ± 6.5 cm and 80 ± 6.6 and 64 ± 6.5 kg in Paper III respectively. Prior 
to the intervention, their maximal oxygen uptake (VO2max) was determined using an 
incremental cycle ergometer test until exhaustion. In Paper II, mean ± SD VO2max was 50.9 
± 4.9 ml·kg-1·min-1 for men and 43.8 ± 7.1 ml·kg-1·min-1 for women. In Paper III, mean ± 
SD peak maximal oxygen consumption (VO2peak) was 50.2 ± 4.6 ml·kg-1·min-1 for men and 
41.5 ± 3.6 ml·kg-1·min-1 for women. After inclusion in the study, subjects were randomly 
assigned to either an exercise group (ExG), or a non-exercising control group (CG). There 
were no significant differences between the groups regarding age, height, weight, and 
VO2peak. The ExG performed 60 min of cycling exercise at a workload corresponding to; 50 
% of VO2peak the first 20 min and 65 % of VO2peak during the following 40 min, whereas 
the subjects in the CG were resting. To control for possible circadian rhythm effects, all 
subjects reported to the laboratory in the morning of the intervention and returned back the 
same time the day after. Subjects rested between biopsies and stayed in the laboratory until 
after the 6 h post-exercise biopsy and returned to the laboratory the next morning for the 24 h 
biopsy. All subjects were given standardized meals the night before, during the day of, and on 
the morning after the intervention. Muscle biopsy samples were obtained at rest, 30 min after 
exercise, 2 hrs, 6 hrs and 24 hrs after the end of exercise. In Paper II, only samples from two 
time points, pre and 30 min post, were used. 
 
3.2.5 12-week training study (Paper IV) 
Overweight or obese males (40-65 years), who did not exercise regularly and who were 
interested in participating in the study and eligible to screening (n=313), were recruited 
through newspapers advertisements and advertisements in local occupational health care 
institutes both from Helsinki and Turku. After a telephone interview, 267 of them were 
recruited to participate in the screening tests. Their health status and suitability for the study 
were checked by a health and lifestyle questionnaire, physical examination and an oral 
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glucose tolerance test. Inclusion criteria were; male sex, age 40-65 years, BMI 25-35 and 
fasting plasma glucose 5.6-6.9 mmol/l and/or 2-hour plasma glucose 7.8-11.0 mmol/l. 
Exclusion criteria were earlier detection of IGT and engagement in prescribed diet or exercise 
programs, engagements in regular and physically very vigorous activities, usage of 
medication affecting glucose balance (e.g. peroral corticosteroid medication). Finally, 144 
volunteers were eligible for the study and equally randomized (1:1:1) into one of three groups 
both in Helsinki and in Turku: (1) a control group (C, n = 47), (2) a Nordic walking group 
(NW, n = 48) or (3) a resistance training group (RT, n = 49). A total of 115 subjects 
completed the study (79.9 %) and from those a subgroup of 61 subjects (NW n=21, RT n=22, 
C n=18) donated muscle samples (n=55 in Paper IV, Preliminary data include n=48). 
Biopsies were obtained before the intervention period and 48-72 hrs after the last training 
session after the 12-week intervention period.  
During the intervention period, some of the subjects dropped out due to private or medical 
reasons, difficulties in work arrangements or deterioration of motivation. Participants were 
advised not to change their habitual diet or their other lifestyle habits during the intervention. 
If they had been somewhat physically active during their leisure-time, they were asked to 
continue these habits. The aim of the intervention program was to be additional to normal 
activity, and should not be taken e.g. from other daily life activities. The study subjects were 
also instructed to avoid alcohol and were advised to keep intake of dietary carbohydrates as 
normal as possible the 3 days preceding sample collection.  
 
The control group, that had no supervised exercise during the intervention period, was 
advised, however, about the health benefits of exercise during the first test day. 
Both intervention groups trained three times per week for 60 minutes per session during 12 
weeks according to special exercise programs in which the exercise intensity was 
progressively increased after every four weeks of training. All intervention programs were 
individually designed and supervised. 
The resistance training sessions included warm-up exercises by either cycling or rowing with 
an ergometer for 5 min followed by stretching. In brief, the resistance program focused on 
strength and power exercises of large skeletal muscle groups, especially those of lower 
extremities and trunk muscles, but also muscles of upper extremities were trained. Exercise 
was performed using regular resistance equipment such as machines, dumbbells and barbells. 
The program included leg press, bench press, leg extension, lateral pull-down, leg flexion and 
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shoulder flexion, explosive leg squats, squat jumps, standing calf jumps or heel raises. Push-
ups, abdominal flexion, and back extension were performed without external weight. External 
loads started at 50 % of exercise-specific maximal strength (pre-determined by 5RM (RM), 
repetition maximum) test according to [(-4.18 x RM-value of load) + 103] (McDonagh & 
Davies 1984) and reached 85 % by week nine, which was sustained until the end of the 12th 
week (week (w) 1-2 at 50 % 2x10 repetitions (reps), w 3-4 at 60 % 3x5 reps, w 5-7 at 70 % 
3x5 reps, w 8-9 at 80 % 3x5 reps, w 10-12 at 80-90 % either 3x3, 1x3 reps or 3x5 reps 
depending on exercise). Training progression was controlled by 5RM strength measurements 
during the seventh training week. At the end of every session, subjects cooled down by low-
intensity cycling or rowing with the ergometer for 5 min and by stretching the main muscle 
groups.  
Before the Nordic walking program began, subjects were familiarized with using the poles in 
a safe and efficient way. All sessions started with 5 min warm-up exercises (400-500 m 
walking) and stretching of the main muscle groups. The exercise sessions were carried out at 
intensity levels increasing from 55 % to 75 % of heart rate reserve (w 1- 4 at 55 %, w 5- 8 at 
65 % and w 9- 12 at 75 %). Individual target heart rates were calculated by using measured 
resting heart rate and the maximal heart rate estimated with the formula [210 - (0.65 age in 
years)]. Heart rate was monitored during training with Polar F4 (Polar Electro Oy, Kempele, 
Finland). The target heart rate range was progressively increased. To achieve the desired 
heart rate target, subjects either increased their walking speed or added uphill walking. After 
the session, the main muscle groups were stretched during a 5-min cool-down.  
 
3.2.6 Animal model, exercise C57B1/6 mice (Paper II) 
To study the BRCA1 expression and regulation in different skeletal muscles, healthy mice 
were used. Male and female C57Bl/6 mice ranging from 8-10 weeks were utilized in this 
study. Mice were randomly divided into either an exercise (male n=6; female n=7) group or a 
sedentary (male n=6; female n=7) group. All animals were treadmill acclimated and then 
only the exercise group was subjected to an acute bout of treadmill exercise (male= 21.92 ± 
0.57 m/min; 40.1 ± 2.75 min; 5 % incline) (female= 26.57 ± 0.30 m/min; 36.5 ± 4.3 min; 5 % 
incline) while the sedentary animals were placed on the treadmill in a stationary position for 
an equivalent time. The males were run at a lower speed to maintain similar relative 
intensities between the males and females. 
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3.2.7 Animal model, High Fat Diet (Paper II) 
To study the influence of high fat diet (HFD) on the BRCA-1 mRNA expression, 12-weeks 
old C57Bl/6 male mice (n=4/group) were placed on a normal chow diet (10 % kcal fat; 
D12450K Research Diets) or HFD (45 % kcal fat; D12451 Research Diets) for 10 weeks. At 
the conclusion of 10 weeks, animals were euthanized and skeletal muscle was harvested, snap 
frozen in liquid nitrogen, and stored at -80°C.  
 
3.2.8 Human primary myocytes, culturing and stimulation (Paper I, II) 
To examine the exercise mimicking effects on skeletal muscle PGC-1a gene expression, cells 
were stimulated with either 5-aminoimidazole-4-carboxamide ribofuranoside (AICAR) or 
beta-adrenergic compounds. In Paper I, to start a human primary cell line 50 mg skeletal 
from the m. vastus lateralis was obtained from two female and two male subjects (healthy 
and normal weight) at rest and stored in sterile phosphate-buffered saline containing 1 % 
penicillin-streptomycin at 4°C overnight. Extraction of cells from the biopsy sample was 
performed as described previously (Blau & Webster 1981), with some modifications. In brief, 
the sample was washed, minced, and dissociated enzymatically in 5 ml of 0.25 % trypsin-1 
mM EDTA (all cell media were from Invitrogen, Stockholm, Sweden) at 37°C and 5 % CO2 
with gentle agitation for 20 min. Undigested tissue was allowed to settle for 5 min, and the 
supernatant was collected in growth medium [Dulbecco’s modified Eagle’s medium 
(DMEM-F-12) and 1 % penicillin-streptomycin] containing 20 % fetal calf serum (FCS). 
Digestion of the slurry was repeated twice. The cells were cultured in T75 flasks (Sarstedt, 
Stockholm, Sweden), and growth medium was changed every 3rd or 4th day until 60 % 
confluency was reached. For the experiment, myoblasts were grown in growth medium 
containing 20 % FCS. At 80 % confluency, the medium was replaced with differentiating 
medium (DMEM-F-12 and 1 % penicillin-streptomycin) containing 2 % FCS. On day 5 of 
culture with differentiating medium, the cells were treated with either AICAR (1 mM, Sigma 
Ald. A1393), norepinephrine (NE; 5µM, Sigma Ald. 099K0978), a combination of AICAR 
and NE, or not treated (control) for 24 h. In Paper II, to determine if BRCA1 plays a critical 
role in the regulation of skeletal muscle metabolic function we reduced BRCA1 expression 
through shRNA technology. Human skeletal muscle myoblasts were cultured from a m. 
vastus lateralis biopsy from a healthy, lean (normal BMI), 24-year-old female. Low passage 
number (<7) myoblasts were cultured and upon reaching ~90% confluency, myoblasts were 
induced to differentiate to myotubes. All cell culture wells were visually examined to ensure 
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that myotubes covered 90% of the well prior to any experimental utilization. To reduce 
BRCA1 content in the human myotubes, the cells were transduced with either scrambled 
shRNA adenovirus (scrambled-shRNA) or adenovirus containing an shRNA sequence 
targeting the coding region of BRCA1 gene overnight (nt.530-550_NM_007294, shRNA-
hBRCA1) and containing a red fluorescent protein (RFP) tag (Vector Biolabs, Philadelphia, 
PA). After the transduction phase, myotubes were returned to regular growth media for 48 hrs 
and equivalent adenovirus infection was confirmed via imaging detection of RFP. To confirm 
reduction of BRCA1 expression, BRCA1 mRNA was isolated from adenovirus-infected 
human myotubes. Reduction in BRCA1 mRNA expression was confirmed in human 
myotubes 72 hrs post adenovirus infection using primers for BRCA1 total, BRCA1D11, and 
BRCA1D11b. In Paper II, shRNA-BRCA1 or scrambled-shRNA treated human myotubes 
were also incubated in 30µM BSA-conjugated palmitate/oleate mixture to study fat 
accumulation (See immunohistochemistry section).  
 
3.3 PHYSIOLOGICAL TESTS  
3.3.1 VO2 max 
Maximal oxygen uptake was first described by Hill and Lupton back in 1923 (Hill & Lupton 
1923) as a measurement of a person’s VO2max and defined the limits of the cardiovascular 
and respiratory systems ability to transport oxygen. Since then it has been a commonly used 
test to measure a person’s cardiorespiratory fitness. In Papers I, II and III an incremental 
cycle ergometer test until exhaustion was performed to evaluate the subjects´ fitness status. 
During the test, respiratory gases were continuously analyzed (Sensor Medics Vmax 229; 
Intra Medic AB, Bålsta, Sweden). All subjects rated their effort on a Borg Scale (ranging 
from 6 to 20) each minute during the test. Subjects in Papers I and II with a VO2max <65 
ml·kg-1·min-1 and in Paper III with a VO2max <60 ml·kg-1·min-1 (men) and <50 ml·kg-
1·min-1 (women) were included. These inclusion criteria were set since an elite athlete training 
status might diminish the possibility of detecting significant exercise effects. In Paper III the 
oxygen consumption is presented as VO2peak instead of VO2max, since some of the subjects 
could not for certain reached their VO2max per definition (Hill & Lupton 1923). VO2peak is 
usually easier to define and determine, but its relevance and connection to physiological and 
pathophysiological status is inferior that of VO2max.  
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3.3.2 UKK-test 
The UKK Walk Test was originally developed by the Urho Kaleva Kekkonen Institute for 
Health Promotion Research (the UKK Institute) in Finland. The UKK- test is a 2-km walking 
test, and a simple and safe physical fitness test designed to measure the respiratory and 
cardiovascular performance of normally active men and women and is commonly used in 
patients and subject with higher BMIs. In study IV all included subjects performed the UKK-
test on a 200m athletic track. VO2max was predicted from the UKK test using gender-
specific equations including age, BMI, performance time of the walk and heart rate 
immediately after the finish (Laukkanen et al. 2000). For VO2max values in ml x min-1 x kg-1 
the following regression equations were used: 184.9 - 4.65 (time) - 0.22 (HR) - 0.26 (age) - 
1.05 (BMI) for men, and  116.2 - 2.98 (time) - 0.11 (HR) - 0.14 (age) - 0.39 (BMI) for 
women. Since this test is based on an algorithm, it is not recommended as a test of fitness for 
extremely fit individuals.  
 
3.3.3 OGTT 
The oral glucose tolerance test (OGTT) is a commonly used test to determine the glucose 
uptake and turnover after an overload of glucose that gives rise to an elevation of glucose 
levels. In study IV, all subjects were given 75 g of glucose to assess subsequent glucose 
levels. In brief, after an overnight fast (12 h) blood was taken from the brachial vein before 
the intervention and after the 12-week intervention period. Immediately after fasting blood 
samples were taken, and all subjects consumed a bottle of GlukodynR, which consists of 75 g 
glucose in 330 ml water. Two hours after the participant had consumed the glucose liquid the 
two-hour glucose sample was taken.  
 
3.3.4 Insulin sensitivity 
Plasma glucose was analyzed by enzymatic photometric method (Konelab Glucose HK). 
Glycated hemoglobin (HbA1c) and serum hs-CRP based on immunoturbidimetry were 
analyzed with routine standardized methods using a Konelab 20i analyser (ermo Clinical 
Labsystems Oy, Konelab, Finland). Serum insulin was analyzed by chemiluminescence-
immunoassay using an Immulite 1000 analyser (Siemens Medical Solutions, Espoo, Finland). 
Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated as follows: 
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HOMA-IR fasting serum insulin (µU/mL) x fasting plasma glucose (mmol/L) / 22.5 
(Matthews et al. 1985). 
 
3.4 BIOCHEMICAL ANALYSIS  
3.4.1 Protein extraction 
In all paper and Preliminary data from study 4, human skeletal muscle samples 
(approximately 20 mg) were homogenized with either glass homogenizers (Paper I-III) or 
by using a bead homogenizer (Retsch MM401) (Paper IV and Preliminary data) in 
homogenization buffer containing: (Paper I) 20 mM HEPES (pH 7.5), 0.2 mM EDTA (pH 
7.4), 1.5 mM MgCl2, 100 mM NaCl, 1 mM Na3VO4, 2 mM dithiothreitol, and 0.4 mM 
phenylmethylsulfonyl fluoride. NaCl (4 M) was added to a final concentration of 450 mM. 
After centrifugation at 23,000 g for 10 min, at 4°C, supernatants were mixed with an equal 
volume of 20 mM HEPES (pH 7.5), 0.2 mM EDTA (pH 7.4), 1.5 mM MgCl2, 450 mM 
NaCl, 1 mM Na3VO4, 2 mM dithiothreitol, 0.4 mM phenylmethylsulfonyl fluoride, and 40% 
glycerol, or in RIPA buffer (Papers II-IV and Preliminary data) containing: 100 mM NaCl; 
50 mM Tris Base; 5 mM EDTA (pH 7.4); 0.5 % Na3VO4; 0.1 % SDS, 1 % Triton-X100; 1x 
tablet of complete protease inhibitor cocktail and 1x PhosStop (Roche Diagnostics). The 
homogenate was gently rotated at 4 °C for 1 hr, followed by centrifugation at 4 °C for 10 min 
(15,000 g).  In the animal study (Paper II) mouse skeletal muscle was mechanically 
homogenized according to previously described techniques (Jackson et al. 2011; Wohlers et 
al. 2011). In brief, mice skeletal muscle biopsies were homogenized on ice using glass-on-
glass homogenizers in RIPA buffer (150 mM NaCl, 10 mM Tris-HCl, 5 mM EDTA, 0.5 % 
Na3VO4, 0.1 % SDS, 1 % Triton X-100, 1x tablet of complete protease inhibitor cocktail 
(Roche Diagnostics).  
Protein extraction from human differentiating myoblasts or myotubes (Paper II), was 
performed by replacing the medium with 2% horse serum and allowed to incubate until 
designated time points (myoblasts 48 hrs and myotubes 96 hrs). When cells were harvested, 
plates were removed, the medium was aspirated, and the cells were washed with ice-cold 
sterile PBS two times. The cells were lysed and scraped in ice-cold cell lysis buffer (50 mM 
Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 10% glycerol, 
200 mM NaF, 20 mM sodium pyrophosphate, 10 g/ml leupeptin, 10 g/ml aprotinin, 200 mM 
phenylmethylsulfonyl fluoride, and 1 mM Na3VO4). Cell extracts were then rotated for 30 
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min at 4 °C and centrifuged at 13,000 g for 10 min.  Total protein was determined in each 
sample using the Bradford protein assay (human) and the Pierce BCA protein assay (mouse). 
All samples were stored at -80°C until future analysis.  
 
3.4.2 Immunoblotting 
In Paper I, skeletal muscle homogenates (40 µg/sample) were separated using 10 % SDS-
PAGE. The proteins were blotted onto nitrocellulose membranes (Bio-Rad), and membranes 
were blocked in 5 % BSA in Tris-buffered saline-Tween 20 (TBST) for 1 h at room 
temperature and then probed with primary antibodies and diluted in 5 % dry non-fat milk in 
TBST overnight at 4°C. After being washed in TBST, membranes were incubated for 1 h at 
room temperature with an anti-rabbit IgG horseradish peroxidase-conjugated secondary 
antibody (New England Biolabs). Bound antibodies were detected using the Immun-Star 
WesternC Chemiluminescence Kit (Bio-Rad) or the SuperSignal West Femto Maximum 
Sensitivity Substrate (Pierce) according to the respective manufacturer’s instructions. 
Loading uniformity was performed by Ponceau staining. Films were scanned and quantified 
densitometrically using Quantity One software (Bio-Rad). In Paper II, 75 µg of muscle 
homogenate was loaded on a 6-10 % SDS-PAGE gels and transferred to polyvinylidene 
fluoride membranes (PVDF). Ponceau staining was used to visualize blots and confirm equal 
loading of each lane on the gel. Membranes were then blocked with 3 % non-fat dry milk in 
TBST for 1 h and then probed with antibodies dissolved in a buffer of 5 % bovine serum 
albumin in TBST on a rocker at 4°C overnight. Following incubation with the primary 
antibody, membranes were washed in TBST (3 times for 5 min) and then incubated for 1 h 
with horseradish peroxidase-conjugated rabbit secondary antibody in 3 % or 5 % non-fat dry 
milk in TBST. Next, membranes were washed in TBST (1 time for 10 min, 3 times for 5 
min), followed by chemiluminescence reagent (PierceProtein Research). Membranes were 
visualized with a chemilumiscence imager (Syngene, Frederick, Md., USA) and quantified 
with Image J software (National Institutes of Health, Bethesda, Md., USA). In Paper III, 
skeletal muscle homogenates (20 µg protein/sample) were separated electrophoretically on 4-
15 % SDS-PAGE gels (BioRad, Stockholm, Sweden) and proteins were then blotted onto 
PVDF membranes (Millipore, Billerica, MA). The membranes were blocked for 1 h at room 
temperature in blocking reagent (Millipore) and then incubated with primary antibodies. 
Beta-tubulin was used as loading control. All primary antibodies were diluted in blocking 
reagent: ddH2O (1:1) and incubated overnight at 4°C, and 45 min at room temperature the 
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day after. After washing with PBS-T (0.1 % Tween 20), membranes were incubated for 1 h at 
room temperature with IRDye secondary antibody (LI-COR Biosciences, Cambridge, UK). 
Membranes were scanned using Odyssey SA Infrared Imaging System (LI-COR Biosciences) 
and quantified using ImageJ.  
 
3.4.3. Enzyme-linked immunosorbent assay (ELISA) 
To measure protein levels of the humanin peptide, enzyme-linked immunosorbent assay 
(ELISA) was used. 100 µg protein of skeletal muscle homogenates were loaded per well, and 
for serum measurement 100 µl of 1:2 dilution was loaded per well (Paper IV, MyBioSourse 
#MBS744343).  
To measure protein levels of MOTS-c, RIP140 and MEF2A, skeletal muscle homogenates 
(between 10-100 µg protein/well depending on the kit) and 100 µl of 1:4 dilution of serum 
were loaded on a competitive or direct ELISA (Preliminary data, MOTS-c; MyBioSourse 
#MBS2033671, RIP140; Blugene #E01N0045/#ABIN1143549, and MEF2A; Wuhan EIAab 
Science #E9776h/#ABIN1143549). All samples were loaded in duplicates and processed 
according to the manufacturer’s instructions. Plates were scanned using a Microplate 
Photometer (SYNERGY 2 BioTek, USA, Winooski) with a 450 nm filter.  
 
3.4.3 Immunoprecipitation 
To study the interaction of BRCA1 and ACC-p in Paper II immunoprecipitation was 
performed of endogenous BRCA1 protein both in human and mouse tissue. In brief, 
endogenous BRCA1 protein in mouse (500 µg total protein) or human (150 µg total protein) 
skeletal muscle homogenate were incubated with 2 µg BRCA1 antibody (I-20, sc-646, Santa 
Cruz Biotechnology, Santa Cruz, CA) overnight at 4oC. The antigen-antibody complex was 
combined with protein A affinity and then washed through repeated centrifugation steps. 
After the final wash the pellet was suspended in sample buffer and heated to 100oC for 5 min. 
The sample was then cooled and the eluted protein was loaded onto an SDS-PAGE gel for 
Western blot analysis (see immunoblotting).   
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3.4.4 Nuclear and Cytoplasmic fractionation 
Nuclear and cytoplasmic fractions was performed in Paper II and III using the Nuclear and 
Cytoplasmic Extraction Kit (NE-PER Nuclear and Cytoplasmic Extraction Reagents, Thermo 
Scientific, 78833). In brief, 10-20 mg of muscle sample was washed twice in PBS and then 
homogenized in cytoplasmic extraction reagent (CER) I buffer containing protease inhibitors 
(Complete Mini, Roche Diagnostics). The cytoplasmic fraction was extracted using CER II 
buffer according to manufacturer’s instructions. Pellets containing the nuclear fraction were 
washed twice in PBS to remove contaminating cytoplasmic proteins before nuclear proteins 
were extracted in nuclear extraction reagent (NER) buffer. The purity of the fractions was 
tested using Western blot with antibodies specific for the nuclear protein Lamin A/C and the 
cytoplasmic protein beta-tubulin. 
 
3.4.5 Immunohistochemistry 
To assess whether reduced BRCA1 content leads to accumulation of intra-myocellular lipids 
shRNA-BRCA1 or scrambled-shRNA treated human myotubes were incubated in 30 µM 
BSA-conjugated palmitate/oleate mixture in DMEM for 4 hrs as previously described 
(Timmers et al. 2012). Myotubes were then stained with BODIPY (Molecular Probes, 
Carlsbad Calif, USA)and imaged at 20 x magnification using a Zeiss Axiovision 4 (Zeiss, 
Oberkochen, Germany) as previously described (Spangenburg et al. 2011).  
 
3.4.6 RNA extraction 
Total RNA was extracted from skeletal muscle biopsies and from cells using the Trizol® 
reagent, based on the acid phenol method earlier described (Chomczynski & Sacchi 1987). 
The integrity of total RNA was determined using 1% agarose gel electrophoresis. Total RNA 
was analyzed (concentration and quality) spectrophotometrically by measuring absorbance at 
260 nm (Nano- Drop 2000; Thermo Scientific, Gothenburg, Sweden). In brief, each sample 
was homogenized with a polytron on ice (Papers I, II and III) or by using a bead 
homogenizer (Mixer mill Retsch MM400, Haan, Germany) (Paper IV and Preliminary 
data form study 4). Total RNA was precipitated using isopropanol, the final RNA pellet 
diluted in RNase-free water and stored at -80°C.  
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3.4.7 Primer design and isoform detection 
Table 2. Primer sequences for designed primers used in this thesis.  
 
In Paper I, we identified PGC-1a splice variants transcribed from the canonical and the 
proposed upstream-located promoter (exon 1a and 1b). This was done by using the NCBI 
genome database and modified PGC-1a primers to fit the human genome from mouse 
primers published previously (Chinsomboon et al. 2009). In Paper III, we used primers 
designed by Ydfors et al. 2013 (Ydfors et al. 2013) to measure the exercise response in two 
additional PGC-1a splices (trunc-PGC-1a and non-trunc-PGC-1a). For a detailed 
description of the different PGC-1a splice transcripts, see Ydfors et al. 2013 and Fig. 7 
below.  
  
Amplicon	Name Forward	Primer	Sequence Reverse	Primer	Sequence
GAPDH ACAGTTGCCATGTAGACC TTTTTGGTTGAGCACAGG
Total	PGC-1α GTGGTGCAGTGACCAATGAG CTGCTAGCAAGTTTGCCTCA
PGC-1α-ex1a TGTATGGAGTGACATCGAGTGT GCTGGTCTTCACCAACCAGA
PGC-1α-ex1b GACACACATGTTGGGGTTATCA ACCAACCAGAGCAGCACATTT
trunc-PGC-1α CCACACACAGTCGCAGTCACA GTCACTGGAAGATATGGCACAT
non-trunc-PGC-1α CCACACACAGTCGCAGTCACA GGGAACCCTTGGGGTCATTTG
Brca1	mouse CACAG	GTATGCCAGAGAAA ATCCTGGGA	GTT	TGCATTTG
BRCA1	total	human TAGGGCTGGAAGCACAGAGT AATTTCCTCCCCAATGTTCC
BRCA1∆11	human GATTTGAACACCACTGAGAAGCGT CAGAGGAGTCACTTATGATGGAAGGG
BRCA1∆11b	human AACCACAGTCGGGAAACAAGCAT TTCTGACCAACCACAGGAAAGCC
Total	LIPIN-1 ACATGAACACATCTGAGGATGAG TAGGTGTTGAAGGTCGGGAAC	
LIPIN-1α ACATGAACACATCTGAGGATGAG	 AGGTCGGGAACCGGAAGGACTG	
LIPIN-1β ACATGAACACATCTGAGGATGAG	 TCCGAAGGATGGAACAGGGA
NCoR1-1 TGACAACCTCTTACAGCAGCA	 GGGCTTGACAGCTTCAACTTC	
NCoR1-2 ACTACTAAAGGATGCCAGTAACATT	 ATGTCTTCCAGCACAAAGATGA	
NCoR1-3 GGATGTGTCCAAAACAAAAGAGATA	 TGGTGATTCCTGCTGTGGTC	
MT-RNR2 AATCACTTGTTCCTTAAATAGGGACC GAACCCTCGTGGAGCCATT
MT-RNR2L1 CACTTGTTCCTTAAATAGGGACTTGTC AGCTGAACCCTCGTGGAGC
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Figure 7. Schematic representation kindly provided by Ydfors et al, 2013. The figure displays exons 
1–7 of the human PGC-1a gene. Primer pairs are depicted to the left, and the resulting splice 
variants measured and promoter sites are depicted to the right. Upper panel: resulting amplicons 
with RT-PCR. Lower panel: amplicons measured with real-time RT-PCR. Exon 1b is transcribed from 
the alternative promoter, and exon 1a is transcribed from the proximal promoter. Exon 7a (ex7a) is 
the exon insert resulting in the truncated forms of PGC-1a (trunc-PGC-1a) and exon 7b (ex7b) is 
present in non-truncated PGC-1a (non-trunc-PGC-1a). The corresponding names of previously 
described splice variants are stated to the right in the upper panel and some of them are used in 
Paper I. 1Zhang et al. (2009), 2Ruas et al. (2012), 3Miura et al. (2008). 
 
 
In Paper III, we also identified and measured LIPIN-1, LIPIN-1a, and LIPIN-1b, based on 
the first publication that described LPIN1 splice variants in the mouse (Péterfy et al. 2005). 
All primers for detection of human LPIN1 transcripts were designed by alignment of mouse 
and human sequences from the NCBI genome database similar to that of the PGC-1a splices 
in Paper I, see Fig. 8. By using the NCBI genome database we also found isoforms of 
NCoR1 that have not previously been analyzed in skeletal muscle, primers were design for 
NCoR1-1, NCoR1-2, and NCoR1-3 isoforms respectively, see Fig. 8. In Paper II, the two 
documented variants of the BRCA1 gene, BRCA1Δ11 or BRCA1Δ11b, were studied by 
designing primers as previously described (Wilson et al. 1997), for sequences see Tab. 2.  
All primer used in this thesis were designed to cover exon-exon boundaries to minimize 
amplification of genomic DNA.  
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Figure 8. Description of LIPIN-1 and NCoR1 primers (A-B), and visualization of RT-PCR products (C-
D) shown. For detailed description see Paper III. 
 
3.4.8 Reverse transcription polymerase chain reaction (RT-PCR) 
RNA was reverse transcribed (total volume of 20µl) using random hexamer primers (Roche 
Diagnostics, Mannheim, Germany) and 2µg of total RNA and the Superscript reverse 
transcriptase kit (Life Technologies, Stockholm, Sweden (Papers I, II and III)) or 1µg of 
total RNA and the High Capacity Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA, USA (Paper IV and Preliminary data form study 4). Samples were stored at -
80°C until further use.  
 
3.4.9  Quantitative real-time PCR (qRT-PCR) 
qRT-PCR was used for mRNA quantification in all Papers included in the thesis and in 
accordance with the MIQE guidelines (Bustin et al. 2009). For gene transcripts shown in 
Table 1, SYBR green analysis was performed (SYBR Green PCR Master Mix, Applied 
Biosystems). The total reaction volume was 10-15 µl, containing 2-5 µl cDNA sample. Final 
concentration of the primers was 0.3-0.4 µM (for details see specific Papers) and all samples 
were loaded in duplicates. All quantification reactions were controlled with a melting curve, 
and primer efficiency was tested using standard curves. For quantification of the remaining 
factors, TaqMan Gene Expression Assays (Applied Biosystems) were used. Total reaction 
volume for TaqMan analysis was 10-25 µl, containing: 2-5 µl cDNA sample; 5-12.5 µl 
TaqMan Fast Universal PCR Master Mix (Applied Biosystems); and 0.5 µl gene-specific 
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primers. All samples were loaded in duplicates. Reaction volume varied dependent on the 
plate and machine used (96-well MicroAmp Optical plates, Applied Biosystems 7500 Fast 
Real-Time PCR System or the 384 well Hard-Shell PCR plate with the Bio Rad CFX384 
Real Time System C100 Touch Thermal Cycler, for details see specific Paper of interest). In 
Paper I, 18S rRNA was selected as an endogenous control, in Papers II and IV 
glyceraldehyde dehydrogenase (GAPDH) was used. In Papers III and IV 40S ribosomal 
protein S18 (RPS18) was used (not published) as an additional endogenous control to 
GAPDH. The cDNA concentration, annealing temperature and thermocycling conditions 
were optimized for each primer pair and gene target, and assay sensitivity was high for all 
PCR products (RSq > 0.99, and efficiency > 90%) (Schmittgen et al. 2000). For each subject, 
all samples were simultaneously analyzed in the same assay. The expression of each target 
gene was then evaluated by the threshold cycle (Ct), also called the quantification cycle (Cq), 
method (2-ΔCt). This method provides the level of expression of the target gene relative to the 
level of expression of the reference gene in each sample (Schmittgen et al. 2000; Bustin et al. 
2009). 
 
3.4.10  DNA extraction 
In Paper IV DNA was isolated with a modification of the Gentra Puregene Tissue Kit 
(Qiagen). In brief, 5-10 mg skeletal muscle tissue was homogenized in lysis buffer (Puregene 
cat.# D-5002) with proteinase K (Qiagen cat.# 19131), and incubated at 55°C for 1 h. Protein 
was precipitated followed by centrifugation 3 min at 14,000 g. DNA was subsequently 
precipitated using ice-cold isopropanol. DNA was washed in 70 % EtOH and mixed with 50 
µl of DNA hydration solution (Puregene cat.# D-5004). After incubation at 65°C for 1 h, the 
concentration and quality of the DNA was analyzed using a Nanodrop® 2000 
spectrophotometer (NanoDrop 2000; Thermo Scientific, Gothenburg, Sweden). 
 
3.4.11  mtDNA and nuclear DNA fraction 
The ratio of mtDNA to nuclear DNA (nucDNA) have been used as a  marker for 
mitochondrial content (Sparks et al. 2005; Swerdlow et al. 2006; Rabøl et al. 2009; Guo et al. 
2009; Tong et al. 2011). The mitochondrial DNA content per genome was then calculated as 
the ratio of the mtDNA to the genomic DNA for each sample. 
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Total DNA was isolated as described above. Analysis were performed in 384-well Hard-Shell 
PCR plates (#HSP3951, Bio Rad), with sample duplicates, using the Bio Rad CFX384 Real 
Time System, C100 Touch Thermal Cycler. DNA was diluted to a concentration of 10 ng/ul 
and for mtDNA analysis samples were diluted 1:10000. The total reaction volume was 10 µl, 
containing: 2 µl DNA sample; primer forward (final concentration 0.3 µM); primer reverse 
(final concentration 0.3 µM); and SYBR Green PCR Master Mix (Applied Biosystems). 
Cycle parameters: one cycle of 95°C for 3 min, followed by 40 cycles at 95°C for 10 s and at 
60°C for 30s, followed by one cycle 95°C for 10 s, 65°C for 5 s and lastly 95°C for 5 s. In 
Paper IV, human nuclear DNA was analyzed by measuring the Myogenin promotor 
(forward primer: AGGTGCTGT CAGGAAGCAAGGA, reverse primer: 
TAGGGGGAGGAGGGAACAAGGA) and mitochondrial DNA was analyzed measuring 
mitochondrially encoded cytochrome c oxidase I gene (COX1,forward primer: 
CCCCTGCCATAACCCAATACCA, reverse primer:CCAGCAGCTAGGACTGGGAGAG) 
(Rabøl et al. 2009).  
 
3.4.12  Enzymatic activity analyses 
3.4.12.1 Citrate synthase  
Citrate synthase (CS) is a rate-limiting metabolic enzyme of the TCA that has been shown to 
reflect the mitochondrial content of skeletal muscle (Holloszy et al., 1970). A well-
established adaptation of skeletal muscle to endurance training is an increase in mitochondrial 
density (Holloszy et al. 1970; Holloszy & Booth 1976; Duscha et al. 2012), which enables 
muscle to produce more aerobic energy. In this sense, CS activity can be used to obtain an 
objective, biochemical indication of the training response. CS activity was measured in 
Paper IV. The assay was performed according to the fluorometric principles of Lowry & 
Passonneau (1972) (L. Lin et al. 1988). In brief, a section of a biopsy was homogenized in 0.1 
M phosphate buffer (pH 7.7) with 0.5 % BSA. For CS analysis, wet tissue lysates were added 
to a reagent solution (0.1 M Tris-HCl, 2.5 mM EDTA, 0.5 mM L-malate, 512.5 nM NAD+, 
399µg MDH). 50 µg acetyl-CoA started the reaction and the velocity was registered with a 
fluorometer (reduction of NAD+ to NADH). A standard curve computed from known 
amounts of NADH was subsequently used to determine the CS activity. Correction for wet 
muscle weight was performed (Vigelsø et al. 2014; Sahin et al. 2006). 
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3.4.13  Mitochondrial respiration and ROS measurements 
3.4.13.1 Agilent Seahorse 
In Paper II, mitochondrial oxygen consumption rates were measured in shRNA-BRCA1 or 
scrambled-shRNA treated human myotubes similar to a previously described technique 
(Schuh et al. 2012; Jackson et al. 2013). Bioenergetic analyses of isolated human myotubes 
were performed using an XF24-3 Extracellular Flux Analyzer (Seahorse Bioscience). All 
cells were cultured and transduced in Seahorse 24-well XF Cell Culture Microplates.  
After calibration of the XF24-3 Extracellular Flux Analyzer, the microplate containing the 
myotubes transduced with scrambled shRNA or shRNA specific to human BRCA1 was 
placed in the analyzer. Basal oxygen consumption rate (OCR; pmol/min) were initially 
quantified across both conditions in assay measurement buffer (MB) at 37°C contained 120 
mM NaCl, 3.5 mM KCl, 1.3 mM CaCl2, 0.4 mM KH2PO4, 1 mM MgCl2, 5 mM HEPES 
(pH 7.4) supplemented with 2.5 mM D-glucose (Sigma G7528) and 0.5 mM L-carnitine 
(Sigma CO158). Mitochondrial respiration was induced with either albumin (03117405001; 
Roche, Indianapolis, IN) conjugated sodium palmitate (palmitate 100 µM, P9767; 50 M; 
Sigma) or sodium pyruvate (10 mM, P8574; Sigma). A second identical treatment of 
substrate was initiated after 20 min and OCR was again recorded. Following the last OCR 
measure induced by the second exposure of substrate, 400 nM carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP, C2920; Sigma) a known inhibitor of 
mitochondrial complex III, was injected to assess non-mitochondrial OCR measures. OCR 
measures presented are the average values detected after the OCR reaches a steady state 
following the introduction of the substrate or FCCP. Basal OCR values presented are taken 
immediately prior to the first injection of either pyruvate or palmitate. The mean derived for 
each group was determined by collecting the average OCR values from 7-10 different wells. 
This results in 25-30 independent measures per group as we previously described.  
 
3.4.13.2 ROS measurements in shRNA-BRCA1 myotubes  
ROS are generated during mitochondrial oxidative metabolism as well as in cellular response 
to xenobiotics, cytokines, and bacterial invasion. Oxidative stress refers to the imbalance due 
to excess ROS or oxidants over the capability of the cell to mount an effective antioxidant 
response. Increased oxidative stress as evidenced by increased 2',7'-dichlorofluorescein 
(DCF) signal can be used to detect increase ROS production/accumulation. In Paper II, 
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Scrambled-shRNA or shRNA-BRCA1 treated human myotubes were placed in DCF 
supplemented KRB buffer for 30 min at 37°C and then washed 3 times. To measure ROS the 
global ROS indicator H2-DCF was used. H2-DCF signed was quantified using a fluorescent 
plate reader (H2, Biotek, Burlington, VT). The myotubes were also visually imaged using an 
inverted epifluorescence microscope (Zeiss, Oberkochen, Germany).  
 
3.4.14  Insulin signaling and glucose uptake in shRNA-BRCA1 
myotubes 
In brief, Ad-shRNA-BRCA1-RFP or AD-shRNA-RFP treated human myotubes were (in 
Paper II) serum starved for 4-5 hrs as previously described (Wohlers et al. 2013). Myotubes 
were then washed three times and incubated with or without 50 nM insulin in warm Krebs 
Ringer (135 mM NaCl, 10 mM NaHCO3, 5 mM KCl, 3 mM CaCl2, 2 mM MgSO4, 1.2 mM 
NaH2PO4) excluding glucose for ~30min at 37°C. At the conclusion of the insulin incubation 
myotubes were exposed to 50 µM 2-NBDG with or without 50 nM insulin for ~30 min at 
room temperature as previously described (Wohlers et al. 2013). Myotubes were then washed 
three times and placed in room temperature Krebs Ringer and 2-NBDG fluorescence (438 nm 
excitation; 535nm emission) and RFP fluorescence (556 nm excitation; 586 nm emission) 
measures were recorded using a BioTek Synergy plate reader (BioTek, Winooski, VT). All 2-
NBDG measures were normalized to RFP values.  
To examine the insulin signaling in human myotubes, Scrambled-shRNA or shRNA-BRCA1 
myotubes were serum starved for 4 hrs in DMEM. Myotubes were then either control treated 
or treated with 50 nM insulin for 30 min.  Protein was then isolated (as previously described 
(Spangenburg 2005)) from control treated or insulin treated scrambled-shRNA or shRNA-
BRCA1 human myotubes.  
 
3.5 STATISTICAL ANALYSES 
In all Papers in this thesis, differences were considered statistically significant at P <0.05. 
Data are presented as means ± SEM and as means ± SD or means (range) when presenting 
the included study subject characteristics. 
In the acute exercise study with or without restricted blood flow (Paper I) a two-way analysis 
of variance (ANOVA) was used for the repeated mRNA measurements (pre, 0 h and 2 hrs 
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post) in the two exercise conditions (R-leg and NR-leg). In the cell culture experiments a one-
way ANOVA was used to identify gene expression changes. Planned comparison was used to 
reveal any internal differences even if there was no overall significance. Since there were 
only a few samples in the protein analysis, a nonparametric Friedman’s analysis of variance 
using ranks for multiple dependent samples was used to evaluate the effects of time (pre, 0 h 
and 2 hrs post) in the exercise condition (R-leg and NR-leg) respectively. In the acute 
exercise study and the animal models in Paper II, repeated measurements ANOVA was used 
and employed with Tukey’s HSD post-hoc tests. Paired and unpaired t-tests were also used.  
Linear mixed-effects models (LMM) enable the modeling of correlated data without 
desecration of important regression assumptions and is efficient in repeated measurements 
analysis and when data are unbalanced (n differ between the intervention groups). This type 
of statistical analysis was used in Papers III and IV. In the acute exercise study with 
repeated biopsies over 24 hrs (Paper III), LMM was used both for gene expression and 
protein analysis with factors time (pre and at 30 min, 2 hrs, 6 hrs and 24 hrs post) x group 
(exercise and control), followed by pairwise comparison within groups using Fisher’s least 
significant difference (LSD) test. The nuclear and cytoplasmic protein analysis was only 
performed in the exercise group and thereby analyzed using one-way ANOVA to identify 
changes from baseline.  
In the 12-week training study in men with impaired glucose regulation (Paper IV), both gene 
expression and total protein abundance were analyzed using LMM with factors time (pre and 
post) x group (exercise and control). If interactions were significant, the analyses were 
followed by pairwise comparison within groups using LSD test and to correct for multiple 
testing, Šidàk correction was performed. In Paper IV, changes between groups regarding 
fitness and metabolic parameters were analyzed with one-way ANOVA. CS activity 
measurements were only applicable in the resistance and the control group and changes in CS 
activity were tested with student’s t-test. Associations between fitness and metabolic 
variables were assessed by Pearson’s correlation test at baseline and compared to both 
humanin protein levels at baseline and ∆ humanin protein. In Papers III and IV, outliers 
were defined using the Inter-Quartile range (IQR) as observations <Q1-(1.5xIQR) or 
>Q3+(1.5xIQR) and excluded from the analysis. 
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3.6 METHODOLOGICAL AND STATISTICAL 
CONSIDERATIONS  
3.6.1 Repeated biopsies  
The skeletal muscle is a perfect tissue to study from a research perspective since it can grow, 
adapt and able to donate small pieces without any seriously harm. In this sense, skeletal 
muscle tissue is really impressive and a genial formed tissue to do research on. Skeletal 
muscle biopsies are used for diagnosis in patients undergoing evaluation for inflammatory, 
metabolic, or mitochondrial myopathies (Goutman & Prayson 2013) . However, in this thesis 
all biopsies were taken on healthy young individuals in all the studies except for study 4 in 
which pre-diabetic older men were included. Performing exercise interventions and studying 
the molecular response in skeletal muscle usually requires repeated biopsy samplings. 
Therefore, it is important to bear in mind that the sampling by itself can elicit some molecular 
changes affecting the results obtained. Repeated biopsies over hours, days or even weeks and 
years are a common feature in the exercise physiology field. Also, how the muscle tissue is 
affected by the invasive biopsy procedure has over the years been explored. In 1992 Staron et 
al. showed that a visual focal damage was induced by the biopsy procedure and that this 
damage was not completely repaired after 2 weeks (Staron et al. 1992).  
Another potential confounding factor in performing exercise studies in humans is the fact that 
multiple muscle biopsies in human skeletal muscle can induce immunological responses 24-
48 hrs after the initial biopsy (Malm et al. 2000). It is highly likely that the procedure 
associated with the biopsy per se evokes a stress response within the tissue. However, a 
biopsy taken within 24 hrs after a first biopsy seems less likely to be affected since the 
inflammation response might not yet have had any influence. A study by Lundby et al. 2005, 
showed that the mRNA responses of specific genes were not affected when two to three 
biopsies had been obtained previously from the same muscle over a 5-6 h period as typically 
used in gene expression studies (Lundby et al. 2005). They also showed that a similar mRNA 
response was observed in the muscle from which 2 or 3 biopsies had already been obtained 
and in the muscle where no biopsy had previously been taken. This was evident both for 
genes directly involved in fat and carbohydrate metabolism and carbohydrate oxidation. Also, 
the mRNA of factors coupled to angiogenesis regulation and stress responsive genes was 
shown to be unaffected by the prior biopsies in the same muscle (Lundby et al. 2005). 
However, more recent findings highlight that that mRNA changes in the non-exerciseing 
skeletal muscle tissue seems mostly to involve factors linked to inflammation, myogenesis, 
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mitochondrial biogenesis, and glucose metabolism, findings which are in contrast to the study 
by Lundby et al. (Lundby et al. 2005; Friedmann-Bette et al. 2012; Van Thienen et al. 2014). 
However, Lundby et al. did not use a control group, rather they used an intra individual 
control. No matter the study design, the specific gene studied should always be compared to 
base line, to a control group or to a housekeeping gene. A recent study by Boman et al. 
concluded that the fiber type composition differed somewhat between biopsies taken from the 
same leg but there were no within-subject differences in gene expression between the 3 
different biopsies where the base line biopsy were obtained 1 h prior to the other biopsies 
(Boman et al. 2015). To conclude, first; in contrast to mRNA analysis, protein measurement 
are more stable and seem not to be as affected by the biopsy procedure itself and secondly; 
gene expression analysis after repeated biopsies separated by a few hours seems less affected 
by the previous sampling than after 24 hrs due to delayed inflammation response.  
 
3.6.2 Protein analysis  
When measuring protein abundance with a semi-quantitative method (Western blot) the 
specificity of the primary and second antibodies is of high importance. In Paper III we had 
huge problem with some of the commercial available antibodies for both LIPIN1 and NCoR1 
proteins. We tried both published and unpublished available antibodies for both of these 
proteins but could not detect bands with the certainty that we wanted (band in the right size 
span on the membranes and low amount of unspecific binding) and could therefore not use 
these data. This resulted in limitations since we only could study the gene expression instead 
of the actual protein and its time-course after an acute bout of exercise. In this study, we also 
performed immunoprecipitation but antibodies that had high binding affinity for the protein 
quantifications (and other antibodies of different brands etc.) did not work for the 
immunoprecipitation protocol (which was modified and also different protocols were tested). 
Therefore, we could not continue with these analyses which limited the possibility to see 
actual interactions of different proteins and transcriptions factors. In Papers II and III precast 
gels were used for the immunoblotting, which can be regarded as more safe and more 
reproducible than preparing own gels as was done in Paper I. Factors that always should be 
Also to bear in mind when using Western blot for protein quantifications is the following; 
possible non-specific protein bindings, the insignificant chance of the target protein to react 
with the secondary antibody and posttranslational phosphorylation or oxidation, all of which 
could result in multiple bands or bands on a different size. Other issues that can affect the 
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analysis include bad gels, dehydrated sandwich and not optimized transfer procedure (time- 
and temperature-wise) which might lead to proteins not transfered to the membrane or just 
partly transferred. Problems with skewed bands can also appear if bubbles are present during 
the transferring of sample from the gel to the membrane and then incubated with antibodies. 
The amount of methanol in the transfer buffer have also been shown to affect the transfer of 
proteins.  
In this sense, it is of high importance to always modify and optimize the protocol for each 
specific protein of interest which has carefully been done during all included Western blot 
analysis in this thesis.    
In Paper IV and Preliminary results from study 4, direct or indirect ELISA was used 
instead of Western blot for the protein analysis. ELISA can be recommended when 
measuring protein abundance in a large number of samples as in study IV. ELISA analysis is 
dependent on high specificity of an antibody, in a combination with a fluorescent enzyme that 
can be converted to a signal and detected. The specificity in the ELISA kit used in this thesis 
was very high, and measurements of total protein concentrations were performed both on 
serum and on skeletal muscle homogenate. ELISA does not display any molecular weight of 
the analyzed protein but instead measures the amount (concentration) of the bound protein to 
a specific antibody by an absorbance technique. However, one advantage of Western blotting 
is that it is less likely to give false positive results, which might be a risk using ELISA since 
you do not see the molecular weight of the captured protein. 
 
3.6.3 To choose a statistical method  
Choosing the right statistical method is sometimes a hazard when conduction research. In all 
of the Papers in this thesis, statistical approaches and analysis have been discussed at length. 
However, in the light of this thesis I would like to state some changes that I might have done 
if the analysis were performed again today. In brief, we performed logarithmic transformation 
to the base 10 of the gene expression data to ensure normal distribution (Paper I). This 
analysis method compress data a lot and I think using the natural logaritm (ln) would have 
been more accurate. Since data of the protein analysis was performed using a nonparametric 
test (Friedman’s analysis of variance) data should have been shown as median instead of 
mean values. Though we wanted to identify changes in mRNA expression and did not really 
know what to expect we should have used pairwise comparison instead of planned 
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comparison. And lastly, in Paper I we also write “planned comparison was used (i.e., post 
hoc test)” which is not accurate since planned comparison is not a post hoc test per definition. 
Also, even though Friedman’s test is generally considered to be a rank randomization 
equivalent of repeated measures ANOVA it is more a sign test (Zimmerman & Zumbo 1993). 
Therefore, a Man-Whitney U test might have been better than Friedman’s test since it was 
two different conditions and repeated biopsy time points. A combination of both Kruskall-
Wallis and Friedman’s test might also have been use otherwise, since there is no applicable 
test in this sense for nonparametric data. In Paper I, subject characteristics were shown as 
means (range) and it would have been more appropriate to show median (range). 
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4 RESULTS AND DISCUSSION 
In four different experimental settings, this thesis has explored factors proposed to be of 
importance for exercise-induced mitochondrial biogenesis and fat oxidation in human and 
mouse skeletal muscle. This thesis aims to explore the interconnected network of 
transcription factors and co-regulators that control the expression of genes encoding 
mitochondrial proteins, including those controlling replication and transcription of the 
mitochondrial genome. The main focus is on the expression of the transcriptional co-activator 
PGC-1α and its surrounding network. Three specific hypotheses of this thesis were that;  
• different PGC-1a transcripts have a markedly differential response to exercise  
• BRCA1 regulate fatty acid oxidation 
• mitochondrial-derived peptides are affected by exercise  
 
4.1 EXERCISE-INDUCED EXPRESSION OF PGC-1a  
4.1.1 Ischemic exercise 
PGC-1a has been shown to be important for the regulation of mitochondrial biogenesis and 
angiogenesis in response to regular exercise, with increased oxidative capacity and oxygen 
delivery as a consequence (D. A. Hood 2006; Arany et al. 2008; Chinsomboon et al. 2009). 
In Paper I, the acute response in skeletal muscle after an ischemic exercise condition was 
investigated. This was done by applying an increased external pressure which results in a 
reduction in oxygen saturation as described in the method section 3.2.3. It was, for the first 
time in human skeletal muscle, shown that PGC-1a can be transcribed from different 
promoters (the canonical and an alternative upstream-located promoter) resulting in splice 
variants of the PGC-1a transcript (PGC-1a-ex1a and PGC-1a-ex1b, in Paper I called PGC-
1α-a and PGC-1a-b), see Fig. 7 for nomenclature and descriptions. 
Interestingly, the PGC-1a-ex1b transcript was almost undetectable at baseline, but had a 
highly-expressed PCR product after exercise (Paper I, Fig. 2). This indicates that PGC-1a-
ex1b could be involved in the initial adaptational process that occurs in skeletal muscle in 
response to exercise, but may not have regulatory functions at rest.  
In Paper I, it was also demonstrated that different PGC-1a transcripts responded differently 
to an ischemic stimulus. A single bout of knee extension exercise with restricted blood flow 
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(R-leg) led to a seven-fold increase of the PGC-1a-ex1a mRNA and over a 100-fold increase 
2 hrs post exercise of the PGC-1a-ex1b mRNA (p= 0.05; Fig. 3 A and B in Paper I). This 
was not only the first time it was shown that the different PGC-1α transcripts are transcribed 
from different promoters but also that different training stimuli affected these transcripts in 
different ways. It was also demonstrated that the pre-exercise expression of the PGC-1α-ex1b 
splice variant was very low compared to that of the PGC-1α-ex1a and that training with non-
restricted blood flow (NR-leg) did not elicit any expressional changes of either splice variant 
(Fig. 2, Paper I). The finding that the total PGC-1a is more affected by ischemic training 
was first described and published by our group in 2004 (Norrbom et al. 2004). The results 
from Paper I provide further support for this previous finding. Recently, studies have shown 
that short burst of sprint-like training and high-intensity interval training (HIIT) can activate 
PGC-1a in a similar way as endurance type training (Burgomaster et al. 2008; Gibala & 
McGee 2008; Little et al. 2010; Hoshino et al. 2016). Reduced blood flow leads to an 
enhanced metabolic stress, why the ischemic training performed in study 1 should be 
considered as high, relative intensity, even though the absolute workload was quite low. 
In support of the notion that exercise with restricted blood flow induced a marked metabolic 
perturbation is that it has been shown to increase skeletal muscle levels of lactate and ATP 
metabolites and a 2 to 3-fold increase in the levels of circulating catecholamines (Sundberg & 
Kaijser 1992; Sundberg 1994). This increased metabolic profile and an increased O2 
extraction seen with restricted blood flow in our previous studies (Sundberg & Kaijser 1992), 
have also been shown in athletes performing isokinetic maximal contractions (Paradis-
Deschênes et al. 2016). In the study by Paradis-Deschênes et al. the training performed was 
classified as high-intensity resistance exercise and a much higher external pressure (200 
mmHg) was employed (Paradis-Deschênes et al. 2016). Blood flow restriction in a resistance 
model in mice has also been shown to increase the expression of known targets for exercise-
induced transcription such as AMPK, a PGC-1a activator (Xu et al. 2016). This supports our 
finding that the activation of PGC-1a might reflect the amount of metabolic stress induced 
and not only the type of exercise per se.  
However, this might be a simplistic explanation and a recently published study, comparing 
blood flow restricted cycling to regular cycling and resistance training, could not detect any 
metabolically beneficial effects when exercise was performed with restricted blood flow 
(Smiles et al. 2017). However, the exercise performed was relatively short, 15 min compared 
to our 45 min of exercise, and the external pressure used was much higher than what we 
applied (90 mmHg). In that study, they did not measure the training response of PGC-1a, but 
  63 
studied factors coupled to autophagy i.e. intracellular processes important for preserving 
cellular homeostasis by degrading nutrient substrates, protein aggregates etc. in response to 
“stress” conditions, such as strenuous contractile activity. It should be noted, however, that 
the same research group in a previous study measured PGC-1a and its splice variants with 
the same exercise protocol and did not find any difference between restricted blood flow 
training compared to regular endurance training (Conceição et al. 2016). If this lack of PGC-
1a response was due to the exercise duration or the exercise type (cycling compared to our 
one-legged exercise) remains unknown, but the differences between those studies and Paper 
I might imply that a longer endurance-based occlusion stimulus may be required to modulate 
MAPK signal transduction (p38 MAPK kinase phosphorylation increases in our study) and 
downstream gene transcription of e.g. PGC-1a. In conclusion, PGC-1a is affected by 
ischemic exercise and it appears that intensity i.e metabolic stress, might be a crucial factor 
for determining the magnitude of the PGC-1a response. Also, in response to exercise, PGC-
1a-ex1b seems like the most exercise-responsive transcript with hitherto unknown 
importance.  
 
4.1.2 Aerobic and resistance exercise 
In this thesis, three different exercise settings were applied to study changes in PGC-1α 
transcript and protein levels with both acute exercise and prolonged training. Interestingly, as 
stated above, non-restricted blood flow exercise did not induce any significant changes in any 
of the three PGC-1a transcripts examined in Paper I, 2h post exercise compared to Pre. This 
could probably be explained by the low absolute exercise intensity performed in the non-
restricted blood flow condition. In contrast to this, subjects in Paper II performed an acute 
and quite intense 60-min exercise bout on a cycle ergometer. In Paper II, the mRNA 
expression of Total PGC-1a, PGC-1a-ex1a, PGC-1a-ex1b, trunc-PGC-1a and non-trunc-
PGC-1a were significantly elevated at 30 min, 2hrs and 6 hrs after exercise. With the 
exception of PGC-1a-ex1a, all transcripts differed significantly from the control group (p< 
0.01; Paper II, Fig. 2 A, B, D, and E).  
The magnitude of the exercise response of the PGC-1a-ex1a transcript was different 
compared to the other transcripts. This indicates that the PGC-1a-ex1a transcript is not as 
sensitive to an exercise stimulus as the other transcripts. This notion is supported by the fact 
that we and others have previously shown similar exercised induced gene expression 
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differences of these transcripts (Norrbom et al. 2011; Ydfors et al. 2013; Lundberg, 
Fernandez-Gonzalo, Norrbom, et al. 2014; Silvennoinen et al. 2015). In Paper III, the 
protein expression of PGC-1a and PGC-1a-ex1b were examined. This was the first time that 
the PGC-1a-ex1b protein was shown in humans. Interestingly, the temporal pattern differed 
between the two proteins. Even though there was no significant interaction between the 
exercise and the control group the PGC-1a-ex1b protein responded and peaked much earlier 
than that of PGC-1α (Paper III, Fig. 7A and B). Total PGC-1a protein levels were 
significantly increased at 24 h after the exercise bout (1.2-fold, p< 0.05; Paper III, Fig. 7A) 
and PGC-1a-ex1b protein levels were increased 3.1-fold at 30 min compared with Pre (p= 
0.05; Paper III, Fig. 7B). The early peak seen for the PGC-1a-ex1b protein might reflect a 
rapid mRNA translation into protein or an increased posttranslational stabilization, resulting 
in a positive protein turnover. Further, this finding could lead to the speculation that the 
activation, rather than increased expression of PGC-1a, mediates the initial phase of the 
exercise-induced increase in mitochondrial biogenesis. An early onset and increased levels of 
PGC-1a protein is in accordance with previous findings in animal and human skeletal muscle 
(Wright, Han, et al. 2007; Perry et al. 2010). 
PGC-1a protein levels after both acute exercise and prolonged training has been studied 
before (Perry et al. 2010; Little et al. 2011), but without including a control group. In this 
regard, it is important to remember that several different stimuli can trigger the expression of 
PGC-1a, i.e. the induction is not solely dependent on exercise (Puigserver et al. 1998; 
Chinsomboon et al. 2009; Norrbom et al. 2011; Ruas et al. 2012) as seen as an induction of 
PGC-1α mRNA also in the control group in Paper III. However, study 3 could not observe 
any significant nuclear accumulation of PGC-1a or PGC-1a-ex1b protein after acute 
exercise, which is in contrast to earlier findings (Little et al. 2011; Safdar et al. 2011). In a 
recent study looking at circadian effects of genes and proteins coupled to mitochondrial 
oxidation, no change over a 24 h time-course with five repeated biopsies was seen of PGC-
1a protein (van Moorsel et al. 2016), which is in line with our results in the control group.  
In Paper III it was concluded, in accordance with Paper I, that PGC-1a mRNA (Paper I 
and III) and protein (Paper III) levels are rapidly elevated by exercise and emphasizes PGC-
1a-ex1b as the most exercise-responsive PGC-1α isoform. The mRNA levels all of the 
different PGC-1a transcripts were back to baseline at the 24 h time point in Paper III. 
Therefore, in study 4 we chose to only look at total PGC-1a and PGC-1a-ex1b expression 
since these are the most exercise sensitive ones. Even though the exercise intensity 
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progressed during the 12 weeks of the study, no significant change in total PGC-1a or PGC-
1a-ex1b expression were seen after the intervention compared to before, or between the 
aerobic, resistance or the control group (Preliminary data from study 4, Fig. 9). The lack of 
PGC-1a response in this study might be explained by the post exercise biopsy time point (24-
72 hrs after the last training session) demonstrating restoration to baseline levels of PGC-1a. 
Importantly, the magnitude of increase after each training session has been shown to be 
progressively decreased, resulting in a stair-case type response over repeated training sessions 
(Perry et al. 2010). Therefore, changes in basal levels of PGC-1a after prolonged exercise 
training interventions are more relevant to study at the protein level.  
 
 
 
Figure 9. Preliminary data, fold change levels of PGC-1a (A) and PGC-1a-ex1b (B) mRNA before 
and after 12-weeks of training, study 4. (RT n= 17, NW n=12 and CON n= 16). Values are presented 
as means ± SEM. 
 
4.2 REGULATORY NETWORK OF PGC-1a 
This thesis mainly focuses on PGC-1a, and by studying PGC-1a per se as well as its 
upstream regulators and downstream targets, and their response to different types and dosage 
(duration and intensity) of exercise training. The purpose was to broaden the perspective on 
the surrounding network of this “master-switch”. Several signaling pathways have been 
suggested to regulate the PGC-1 family. These signaling pathways includes calcium-
regulated pathways, calcineurin and CaMK, and p38 AMPK as well as activation of b2-
adrenergic receptors (Winder & Hardie 1996; Zong et al. 2002; H. Wu et al. 2002; Handschin 
et al. 2003; Kusuhara et al. 2007; Wright, Geiger, et al. 2007; Miura et al. 2007; 
Chinsomboon et al. 2009; Tadaishi, Miura, Kai, Kawasaki, et al. 2011).  
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4.2.1 Upstream signaling, activators and coactivators affecting PGC-1α  
PGC-1α expression levels are regulated by a plethora of stimuli, such as the mechanical 
stretching of the muscle fiber, changes in calcium flux and increased metabolic demand 
reflected by an elevated an AMP/ATP ratio. The results from Paper I, clearly demonstrates 
that factors coupled to the calcium-activated pathway increased significantly in expression 
and phosphorylation (activity) in response to the intervention (Paper I, Fig. 4 A-C). 
Interestingly, there were no differences in the induction of MCIP1 mRNA (marker for 
calcineurin activation) and p38 mitogen-activated protein kinase (MAPK) protein 
phosphorylation 2 hrs after exercise when comparing the restricted and non-restricted blood 
flow conditions. This might argue against calcineurin and p38 MAPK as candidates for the 
sole regulation of PGC-1a in active skeletal muscle. This argument is also supported by other 
studies challenging the importance of Ca2+ signaling for the activation of PGC-1a in the 
exercising muscle (Garcia-Roves et al. 2006; Ojuka et al. 2003; Vaarmann et al. 2008).  
Studies in humans and animals have shown a link between Ca2+ signaling, basal levels of 
Ca2+ and the activation of PGC-1a, as well as a connection to increased mitochondria density 
(Chin et al. 1998; Olson & Williams 2000; H. Wu et al. 2002; Bruton et al. 2010; Place et al. 
2015). Interestingly, in contrast to MCIP1 and p38 phosphorylation, AMPK phosphorylation 
increased significantly only in the condition with restricted blood flow i.e. higher relative 
exercise intensity (Paper I, Fig. 4 C). This finding suggest that the AMPK pathway  might by 
a strong candidate for the regulation of exercise-induced transcription of PGC-1a. To 
investigate this further, cultured human satellite cells were treated with AICAR (an AMPK 
analog) and/or norepinephrine (NE, a strong b-adrenergic stimulator). AICAR stimulation 
increased the mRNA expression of both the PGC-1a-ex1a and PGC-1a-ex1b splice variants 
as well as the Total PGC-1a (Paper I, Fig. 5). A significant increase in the mRNA levels of 
PGC-1a-ex1a, PGC-1a-ex1b and Total PGC-1a were also seen with the combination of 
AICAR and NE, and with NE treatment alone. Noteworthy, the PGC-1a-ex1b mRNA 
expression increased most in the cells treated with a combination of AICAR and NE. Acute 
b-adrenergic stimulation has been shown to be inefficient in altering PGC-1a expression in 
resting human skeletal muscle (Tadaishi, Miura, Kai, Kawasaki, et al. 2011). 
 It should be pointed out that the resting biopsy in the leg subsequently exercising in a non-
restricted fashion was obtained at the same time point as the biopsy obtained 2 hrs post 
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exercise in the leg trained with restricted blood flow (study 1). This means that the tissues 
(Pre in the NR-leg and 2 hrs post in the R-leg) had been exposed to the same levels of 
circulating catecholamines but there was no induction of PGC-1a-ex1b in the NR-leg at the 
Pre time point (Paper I, Fig. 3). Since almost all tissues throughout the body are exposed to 
exercise-induced changes in the circulating levels of catecholamines, it is unlikely that b-
adrenergic stimulation alone can regulate muscle-specific remodeling in any major way. 
More likely, skeletal muscle adaptation, e.g. mitochondrial biogenesis and angiogenesis, is 
highly specific to the skeletal muscle conducting the exercise and not solely dependent on 
hormonal fluctuations. This supports a strong role of AMPK in the exercise- induced 
upregulation of PGC-1a, and especially the PGC-1a-ex1b transcript. AMPK has been shown 
to phosphorylate PGC-1α and initiate its activity (Jäger et al. 2007), but interestingly it seems 
like the activation of AMPK on the different PGC-1α promoters might differ (Popov et al. 
2017). Using administration of metformin as an AMPK activator, in an acute exercise trial in 
men it was recently shown that low-intensity exercise markedly increased the expression of 
PGC-1a mRNA via the alternative promoter (PGC-1a-ex1b), without increasing ACCSer79/222 
(a marker of AMPK activation) and AMPKThr172 phosphorylation (Popov et al. 2017). 
However, since that study used low-intensity exercise, we cannot exclude the possibility that 
substantial activation of AMPK might occur after high-intensity exercise or ischemic stress, 
that subsequently affects the expression of PGC-1a mRNA via the alternative promoter 
(PGC-1a-ex1b).  
Further, studies in rodents have shown that b-adrenergic receptor agonists and antagonists 
have strong effects on the expression of PGC-1a mRNA via the alternative promoter, 
probably dependent on the cAMP responsive element-binding protein-1 (CREB1) signaling 
pathway (Chinsomboon et al. 2009; Tadaishi, Miura, Kai, Kano, et al. 2011; Wen et al. 
2014). In support of the hypothesis that b-adrenergic stimulation may not act on its own, a 
study performed in rats treated with the b-adrenergic agonist clenbuterol for 3 weeks showed 
a decrease in PGC-1a mRNA and protein levels, in mitochondrial enzyme activity and in 
markers for mitochondrial content compared to a control group (Hoshino et al. 2011). 
However, this long-term administration, mimicking long-term stress, might also 
downregulate stress-induced factors such as PGC-1a as a regulatory feedback mechanism. 
The true effect of b-adrenergic stimulation on PGC-1a is still fairly unknown, confusing and 
perplex.  
 68 
Other studies have also reported increased levels of PGC-1a mRNA with compounds such as 
clenbuterol (Miura et al. 2008; Gonçalves et al. 2009). This tells us that the regulation of 
PGC-1a is very diverse and factors that can be activated by PGC-1a can also in some ways 
regulate PGC-1a itself.  
 In this sense, a factor that both act on and is regulated by PGC-1a is the tumor protein p53. It 
has been shown that p53 can directly bind to the PGC-1a promoter and thereby increase 
PGC-1a expression (Aquilano et al. 2013). Also, p53 is activated/phosphorylated by muscle 
contraction and metabolic stress leading to nuclear and mitochondrial translocation of p53 
and resulting in the transcription of metabolic genes (Saleem et al. 2013; Saleem & D. A. 
Hood 2013). Metabolic stress that results in p53 activation and triggers cell-cycle arrest, ROS 
clearance or apoptosis can also be regulated by PGC-1a binding to p53 (Sen et al. 2011). 
This binding of PGC-1a to p53 modulates the transactivational function, resulting in 
preferential transactivation of pro-arrest and metabolic target genes of p53. This allow the 
regulation of p53 function by the PGC-1α protein to be seen as a critical switch in 
determining the p53-mediated cell fate. PGC-1α is in that sense defining the p53 response to 
metabolic stress.  
In Paper III, there was a significant interaction between the exercise group and the control 
group as well as over time for p53 mRNA. Interestingly, p53 mRNA was significantly 
induced at some of the time points in the control group, which might indicate a biopsy effect 
(metabolic and/or inflammatory stress of the tissue) (Paper III, Fig. 4 C). Nevertheless, 6 hrs 
after exercise the induction of the p53 transcript peaked (2.9-fold, p<0.01) and this time point 
was not significantly elevated in the control group. The acute response of the p53 transcript 
and protein is still not fully elucidated after this study, e.g. protein was not measured which is 
necessary for the understanding of the activation and temporal resolution of p53 after one 
exercise bout. Acute exercise studies in animals have revealed an important function of p53 
in the metabolic response to training and as an important player in the mitochondrial 
adaptation to exercise (Saleem & D. A. Hood 2013; Saleem et al. 2013). Understanding the 
full potential of p53 in response to exercise and in a metabolic perspective in human muscle 
is still warranted.  
Neither PGC-1a (Total PGC-1a), nor its isoforms can bind directly to the DNA. Instead, 
they interact with DNA-binding transcription factors to exert their function. Numerous 
factors have been suggested to co-regulate and co-activate PGC-1a. One of these factors is 
the lipid metabolism enzyme LIPIN-1. In Paper III, we could was shown for the first time 
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that two splice variants of the LIPIN-1 transcript (LIPIN-1a and LIPIN-1b) exist in human 
skeletal muscle (see Fig. 8) similar to what previously had been reported in mouse adipocytes 
(Péterfy et al. 2005). 
LIPIN-1 interacts with and binds to PGC-1α and co-regulates its transcriptional function 
(Reue & P. Zhang 2008; Kim et al. 2013) and plays a role in skeletal muscle mitochondrial 
adaptation after exercise in rodents (Higashida et al. 2008). In Paper III, LIPIN-1 gene 
expression and the exercise adaptive response were studied. Acute exercise significantly 
elevated skeletal muscle LIPIN-1 and LIPIN-1a, but not the LIPIN-1b mRNA expression 
(Paper III, Fig. 3 A-B), compared to the control group. The expression pattern over time was 
rather similar for all the LIPIN-1 transcripts in the exercise group. Similar to p53, an 
induction of the LIPIN-1 mRNAs was detected in the control group. The significant 
difference in expression in the control group at the 24 h time point indicated that it was not an 
artifact due to diurnal changes, but rather something due to the sampling process e.g. 
inflammation. Studies in human skeletal muscle myotubes and in myoblasts have implied a 
link between LIPIN-1 and inflammation, which might be a possible explanation (Michot et 
al. 2013; Meana et al. 2014).  
Repeated biopsies have been performed previously in both animal and human studies. In 
many exercise studies with repeated biopsies, the possible diurnal changes or effects of 
inflammation are not accounted for. Multiple muscle biopsies in human skeletal muscle have 
been shown to induce immunological responses at 24 hrs or 48 hrs after the initial biopsy 
(Malm et al. 2000), which might explain the induction at the 24 h time point of some of the 
factors in Paper III. We included a non-exercising control group in an attempt to isolate the 
exercise-specific effects. The inclusion of this control group thereby minimized the impact of 
e.g. biological variability, biopsy effects, and diurnal changes that previously published 
studies have highlighted (Staron et al. 1992; Malm et al. 2000; Lundby et al. 2005; Lamia et 
al. 2009; Martin et al. 2010; Van Thienen et al. 2014; van Moorsel et al. 2016). However, the 
exercise response of p53 and LIPIN-1 are still not fully understood. It may be concluded from 
Paper III and the study by Friedmann-Bette et al 2012 that, if an intra-individual control or a 
separate control group is not used, false positive results might be found when using repeated 
biopsies to conclude mRNA expression changes in exercise interventions (Friedmann-Bette 
et al. 2012).  
The majority of the mRNAs that changed in the non-exercising skeletal muscle tissue appears 
to involve factors linked to inflammation and glucose metabolism but could certainty involve 
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more factors and pathways. However, a recent study looking at  gene expression and fiber 
type variations in repeated biopsies from the m. vastus lateralis, concluded that gene 
expression differs significantly between individuals but is not affected by repeated muscle 
biopsy sampling from the same subject (Boman et al. 2015). Thus, from a methodological 
perspective it is of value to study gene expression over time after repeated biopsies within a 
subject as was done in this thesis as long as a control group is included.  
Another way that the PGC-1a activity can be regulated and affected is by transcriptional 
modulation and initiation or by binding to a PGC-1a functional protein. Coactivators such as 
PPARg, NRF-1, and NRF-2 are key targets of PGC-1a mediated coactivation, however 
myocyte enhancer factor-2 (MEF2) and the estrogen-related receptors (ERRs) have also been 
shown to be important coactivators for PGC-1a (Finck & Kelly 2006). In Paper III, no 
exercise mediated effect on NRF-1 or ERRa mRNA (Paper III, Fig. 4 A and D) could be 
observed. This lack of NRF-1 induction is consistent with a previously performed acute 
exercise study which also included repeated biopsy sampling over a time course of 24 hrs 
(Pilegaard et al. 2003). Together, these data together indicate that NRF-1 might not be acutely 
regulated by exercise.  
Mice constantly overexpressing NRF-1 have been shown to present increased levels of 
MEF2A and the glucose transporter type 4 (GLUT4) (Baar et al. 2003) which indicate a 
potential role for NRF-1 in the metabolic regulation and exercise adaptation. In Paper III, an 
exercise-mediated effect of the ERRg gene expression could be detected, with a peak at the 6-
hr time point (Paper III, Fig. 4 B). This might reflect that ERRg is more important than 
ERRa as an acute exercise-response target gene. ERRg has been linked to AMPK and is 
presumably important in promoting exercise-induced metabolic adaptations (Rangwala et al. 
2010; Narkar et al. 2011). The activity of the ERRs, especially ERRa, has been shown to be 
inhibited through interaction with the RIP140 protein, a corepressor that antagonizes the 
action of PGC-1a (Qi & Ding 2012) . This suggest that the role of the ERRs in the oxidative 
adaptation to exercise might be of greater importance than initially thought. 
In study 4, protein and mRNA analysis of MEF2A was performed before and after 12 weeks 
of training. It is known that the PGC-1a promoter has binding sites for MEF2A (Czubryt et 
al. 2003; Baldán et al. 2004) and can induce the transcription of the PGC-1a gene. 
Preliminary data from study 4, indicates that 12 weeks of resistance training significantly 
increased the protein levels of MEF2A (see Fig. 10), but no correlation of ∆MEF2A protein 
and ∆PGC-1a or ∆PGC-1a-ex1b mRNA could be detected. MEF2A mRNA levels were not 
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significantly changed in any of the intervention groups in study 4 which is not surprising 
since the post biopsy was taken 24-72 hrs after the last training session. This lack of MEF2A 
mRNA change has also been shown in a previous study, in which no changes were detected 0 
hr or  
3 hrs after an acute bout of exercise (Barrès et al. 2012). This indicates that the window for 
detecting the MEF2A gene activation might have been missed, and that an expression change 
could be speculated to occur between 3 hrs and 24 hrs after an exercise bout. 
A weak correlation was detected between ∆MEF2A and ∆HOMA-IR (r=-0.454, p=0.007) in 
men with IGR (Preliminary data, study 4). Even though the correlation was weak, it is 
strengthened by earlier exercise studies, both in humans and in animals, showing that 
MEF2A is coupled to GLUT4 expression, and that this interaction is coupled to increased 
binding of MEF2A to the promoter of the GLUT4 gene (Smith et al. 2007; Gong et al. 2011; 
E. A. Richter & Hargreaves 2013) and therefore important for glucose regulation.  
 
 
Figure 10. Preliminary data, fold change MEF2A protein levels before and after 12-weeks of training, 
study 4.  ap ≤ 0.05 with factors time x group (LMM). *p ≤ 0.05, compared to Pre (pairwise 
comparison (Sidak correction) within groups). (RT n= 14, NW n=14 and CON n= 14). Values are 
presented as means ± SEM. 
 
To conclude, upstream signaling mechanisms are important to study further in the attempt to 
understand the different functions of PGC-1a and how it is activated. Different types of 
training regimes and stimuli appear to determine which upstream pathway that is activated. 
Therefore, immunoprecipitation experiments are needed to understand the protein-protein 
interactions that might affect PGC-1a activation.  
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4.2.2 PGC-1α inhibitors and corepressors 
Corepressors are proteins that mediate the repressive activity of nuclear receptors and other 
transcription factors. RIP140, is a nuclear receptor interacting protein and a corepressor 
involved in a spectrum of metabolic pathways such as glucose uptake, glycolysis, fatty acid 
oxidation, Krebs cycle, and oxidative phosphorylation (Seth et al. 2007; Frier et al. 2011). 
Previous studies have demonstrated that RIP140 and PGC-1a have opposite effects such that 
transcription factors activated by PGC-1a are repressed by RIP140 (Hallberg et al. 2008; 
Chen et al. 2012). Also, a direct protein-protein interaction between PGC-1a and RIP140 has 
been observed (Gupta et al. 2008; Hallberg et al. 2008). 
 In Paper III, the effect of acute exercise on this corepressor of PGC-1a was studied. There 
was no significant difference between the exercise and the control group regarding RIP140 
gene expression (p=0.06), even though the expression was significantly increased at all time 
points, compared to baseline levels, in the exercise group. This mRNA induction of RIP140 
with exercise is in line with previously published human studies (Frier et al. 2011; Edgett et 
al. 2013). RIP140 protein levels differed significantly between the exercise and the control 
group, and interestingly RIP140 protein was significantly elevated in the control group at 2 
hrs, 6 hrs and 24 hrs after the first biopsy (Paper III, Fig. 6 A). Furthermore, a previous acute 
HIIT study looking at RIP140 protein at 0 hrs and 3 hrs post exercise did not find any 
changes in RIP140 protein in human skeletal muscle (Frier et al. 2011). Taken together, this 
might indicate that exercise halts the inhibitory effects of RIP140 on the oxidative machinery 
and that the biopsy-induced stress per se might activate RIP140. In Paper III, cellular 
location analysis of RIP140 protein was performed and it was found that RIP140 was solely 
located within the nucleus, leading to speculation that this might strengthening its corepressor 
ability and activity (Paper III, Fig. 7 H).  
In study 4, Preliminary data of RIP140 protein showed no significant differences over time 
nor any interactions between the intervention groups, but RIP140 mRNA data was 
significantly decreased in the resistance group over time, see Fig. 11. However, RIP140 
protein levels decreased in all subjects except one in the control group and a trend towards 
increased levels in the resistance group could be seen (p=0.06, Fig. 11). Noteworthy, it has 
been shown in human and rat skeletal muscle that a RIP140 decrease is not required to get an 
increase in mitochondrial content, and 2 weeks of HIIT training did not change RIP140 
protein levels in human skeletal muscle (Frier et al. 2011). Altogether, this supports our 
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finding that exercise does not reduce RIP140 protein content but that exercise per se might 
reduce the stress-induced effect from the biopsy as was found in Paper III.  
 
Figure 11. Preliminary data, RIP140 protein levels in human skeletal muscle (RT n= 14, NW n=14 and 
CON n= 10) (A), and fold change RIP140 mRNA levels (RT n= 17, NW n=12 and CON n= 16) (B) 
before and after 12-weeks of training, study 4.  ap ≤  0.05 with factors time x group (LMM). *p ≤ 0.05, 
compared to Pre (pairwise comparison (Sidak correction) within groups). The bars represent means 
± SEM. 
 
Another transcriptional corepressor shown to interact with proteins involved in the oxidative 
and metabolic machinery is nuclear receptor corepressor 1 (NCoR1). In Paper III, it was 
shown for the first that there are three different isoforms of NCoR1 (NCoR1-1, NCoR1-2 and 
NCoR1-3) expressed in human skeletal muscle, see Fig. 8. 
Similar to RIP140, the program orchestrated by NCoR1 has been postulated to antagonize 
that of PGC-1a (Yamamoto et al. 2011; Perez-Schindler et al. 2012). To what degree NCoR1 
(or its splice variants) might exert inhibitory actions on PGC-1a or on other exercise-specific 
factors after acute exercise in humans could not be elucidated from study 3.  
However, studies in animals have shown that genes involved in mitochondrial biogenesis and 
oxidative phosphorylation are up-regulated in a muscle-specific knock-out model of NCoR1 
and that NCoR1 seems to specifically antagonize the actions of PGC-1a, ERRs and MEF2 
(Perez-Schindler et al. 2012). These common pathways make NCoR1 an interesting target for 
the understanding of the metabolic adaptation in skeletal muscle after exercise. NCoR1 has 
been shown to regulate histone acetyltransferases (HATs) and histone deacetylases (HDACs) 
(You et al. 2013; Mottis et al. 2013). HATs have been shown to usually stimulate gene 
transcription, whereas HDACs typically repress gene expression. Since both NCoR1 and 
HDACs have been linked to regulation of the muscle adaptation machinery and the fact that 
NCoR1 KO-mice show increased muscle volume, muscle mass and strength as well as an 
Resistance Nordic Walking Control
0
1
2
3
RIP140 protein
R
IP
14
0 
pr
ot
ei
n 
le
ve
ls
 n
g/
m
l
 in
 s
ke
le
ta
l m
us
le
Resistance Nordic Walking Control
1
2
3
4
R
IP
14
0 
pr
ot
ei
n 
le
ve
ls
 n
g/
m
l
 in
 s
ke
le
ta
l m
us
le
Pre Post
Resistance Nordic Walking Control
0.0
0.5
1.0
1.5
R
IP
14
0 
m
R
N
A 
le
ve
ls
 (c
om
pa
re
d 
to
 P
re
)
Pre Post
*
BA
 74 
increased mitochondrial capacity (Yamamoto et al. 2011; Mottis et al. 2013; Muoio 2017)  it 
is of profound importance to study NCoR1 further in human exercise studies.   
 
4.2.3 Downstream targets of PGC-1a  
In connection to PGC-1a, nuclear-encoded mitochondrial proteins are located furthermost 
downstream in the proposed machinery of exercise-induced mitochondrial biogenesis. In 
Paper III, some of these factors were measured in an attempt to study if they were activated 
with acute exercise and if the expression pattern correlated with PGC-1a mRNA or protein.  
In Paper III, there was a clear induction of VEGF-A mRNA in the exercise group (Paper 
III, Fig. 5 A) at all time points except at 24 hrs when the levels were back to baseline. VEGF-
A has been shown to peak between 3-6 hrs post exercise in previously publications from our 
research group and others (Breen et al. 1996; T. Gustafsson et al. 1999; T. Gustafsson et al. 
2005). Somewhat surprising, the VEGF-B expression did not respond in the same way as 
VEGF-A and no exercise-mediated effect could be seen (Paper III, Fig. 5 B). It should be 
noted that an absence of exercise-induced VEGF-B expression has previously been observed, 
but at 30 min and 48 hrs after an exercise bout (Kivelä et al. 2007). Following acute exercise 
the TFAM mRNA expression was upregulated while TFB1M and the marker for 
mitochondrial oxidative capacity SDH subunit-A (SDHA) were unaffected (Paper III). In an 
earlier study from our lab it has been demonstrated that  the basal levels of  the TFAM 
protein differed when comparing elite athletes and moderately active individuals (Norrbom et 
al. 2010), indicating its involvement in the regulation of oxidative capacity. The same study 
from Norrbom et al, showed a marked increase in the TFB1M mRNA after 10 days of 
training, indicating that the gene expression regulation of TFB1M might be regulated by 
repeated endurance training and, as shown in study 3, and not acutely regulated after one 
single exercise bout.  
 
4.3 METABOLIC FUNCTION AND REGULATION IN 
SKELETAL MUSCLE 
The metabolic requirements of skeletal muscle are highly variable and capable of adapting to 
increasing or decreasing energy demands as well as to mechanical loading and unloading. 
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Skeletal muscle metabolism is also under hormonal control, e.g by insulin and sex hormones 
such as estrogen (Spangenburg et al. 2012).  
In Paper II, the role of the BRCA1 gene and protein expression in skeletal muscle 
metabolism after exercise was explored using a translational approach. In addition to fat 
metabolism, skeletal muscle is also a major glucose-regulating tissue. In study 4, a 
longitudinal exercise intervention was performed to examine the effects of markers coupled 
to glucose regulation and metabolism in skeletal muscle from persons with IGR (Paper IV 
and Preliminary data).  
 
4.3.1 BRCA1, existence and action in skeletal muscle  
4.3.1.1 Sex and skeletal muscle differences in BRCA1 expression  
The BRCA1 gene produces either a full-length BRCA1 or two variants through alternative 
splicing, BRCA1∆11 or BRCA1∆11b (Wilson et al. 1997). In Paper II, both BRCA1 
isoforms were identified and present in both human and mice skeletal muscle (Paper II, Fig. 
1 mice data and Fig. 3 human data). Neither the BRCA1 mRNA levels (full-length and splice 
variants) nor the BRCA1 protein level differed in expression between sedentary women and 
men (Paper II, Fig. 3 A-C). The short BRCA1Δ11 protein was exclusively detected in the 
cytosolic fraction of the myocyte. This is in line with previously published data showing that 
the short isoforms lacks a nuclear localization signaling element (Wilson et al. 1997; Mok & 
Henderson 2010).  
In mice, there seems to be both a sex and muscle type specific difference in the BRCA1 
protein expression. The m. gastrocnemius in male mice had much greater levels of both the 
full-length and the short (BRCA1Δ11, 85 kDa) BRCA1 splice variant compared to females 
(Paper II, Fig. 1D). These findings were somewhat surprising since BRCA1 is a well- 
established estrogen-sensitive gene (Clemons & Goss 2001; Wang & Di 2014). But it might 
be speculated that the higher BRCA1 content in male mice might be due to the lower 
concentrations of estrogen with a compensatory mechanism to regulate fat oxidation. 
Full-length BRCA1 protein levels did not differ between m. gastrocnemius and m. tibialis 
anterior (TA), but was undetectable in the m. soleus (Paper II, Fig. 1 E and F). This lack of 
BRCA1 in the m. soleus was very unexpected in this highly oxidative muscle. Male mice had 
significantly higher levels of the short BRCA1Δ11 in the TA and m. soleus compared to the 
m. gastrocnemius but in female mice no differences were detected in BRCA1Δ11 protein 
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content among the different muscles. In this regard, the high levels of the short BRCA1Δ11 
in the m. soleus might be suggested to compensate for the absence of the full-length BRCA1 
protein. 
Estrogens have a powerful influence on both fat and carbohydrate utilization and metabolism 
in peripheral tissue, thereby significantly affecting metabolic flexibility in women (Campbell 
& Febbraio 2001). This flexibility effect seems to result in an ability to maintaining both a 
greater insulin sensitivity as well as having a greater capacity to oxidize lipids (Høeg et al. 
2011). As a consequence, younger women have been shown to exhibit a greater difference in 
the respiratory quotient (RQ) from a fasted to a fed state compared to men (Høeg et al. 2011), 
and interestingly this effect seems to be opposite in older women and men with a different 
estrogen profile (Toth et al. 1998). This is in accordance with several studies showing that 
women use more of the oxidative system coupled to fat oxidation than men both at rest and 
during exercise (Horton et al. 1998; Friedlander et al. 1998; Carter et al. 2001; Maher et al. 
2009; Lindholm et al. 2014). 
However, metabolic flexibility in women is impaired in response to loss of circulating 
estrogens during menopause, thus increasing the risk for the development of type 2 diabetes 
and the metabolic syndrome (Campbell & Febbraio 2001). What role BRCA1 plays in the 
metabolic differences seen between the sexes still necessitates further investigations.  
 
4.3.1.2 BRCA1 regulation of fat oxidation 
Analysis in Paper II clearly showed that both acute exercise and high fat diet could regulate 
and elicit changes in BRCA1 protein and mRNA expression. An acute bout of exercise 
resulted in a significant increase in ACC-p/ACC total compared to before exercise in human 
skeletal muscle (Paper II, Fig. 4 A and B). There was considerable inter-individual 
variability in the magnitude of interaction between ACC-p and BRCA1 in both women and 
men at baseline and after exercise but no significant difference between the sexes could be 
detected (Paper II, Fig. 4 C). This lack of difference in the interaction between ACC-p and 
BRCA1 might be due to the small sample number. By pooling the data from both women and 
men, an increased protein interaction of ACC-p and BRCA1 could be detected as an exercise-
response (Paper II, Fig. 4 D-E). In mice subjected to an acute bout of treadmill exercise, a 
significant elevation of the ratio of ACC-p/ACC-total and an increased BRCA1-ACC-p 
protein-protein interaction in both female and male m. gastrocnemius were found, compared 
to sedentary mice. Previously, studies have assigned MaCoA as a potent allosteric inhibitor of 
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carnitine palmitoyltransferase 1 (CPT-1) and that it  serves as a precursor for lipid synthesis 
(McGarry et al. 1983; Winder & Hardie 1996). As anticipated, MaCoA content significantly 
decreased in response to the exercise bout in the female animals, but surprisingly, the increase 
in ACC-p levels did not correspond to a decline in MaCoA levels in the male mice (Paper II, 
Fig. 2 C). However, MaCoA levels in sedentary female skeletal muscle were significantly 
higher compared to sedentary males. In human breast cancer cells the interaction of BRCA1 
and ACC-p has previously been described as an important step in the regulation of lipid 
metabolism (Magnard et al. 2002; Moreau et al. 2006). Taken together, this emphasizes that 
exercise might inactivate ACC in both humans and mice and thereby increase the fatty acid 
transport over the mitochondrial membranes. To confirm this, re-analysis of data from a 
previous study (Thomson et al. 2007) which showed that AICAR stimulates a decrease in 
MaCoA content, was performed. This re-analysis showed that female mice had higher levels 
of resting MaCoA and had a greater response to AICAR treatment than age-matched male 
mice. The exercise effect on MaCoA needs further evaluation but it is possible that exercise 
might decrease the levels of MaCoA at least in female mice. Whether there is a similar sex 
difference, at rest or after exercise, in humans could unfortunately not be concluded from 
these results. Even though MaCoA could not be measured due to limited  biopsy material in 
study 2, acute exercise has previously been shown to reduce the MaCoA content in human 
muscle after exercise (Dean et al. 2000; Frøsig et al. 2009). 
 Still, the regulatory mechanisms of BRCA1 might be more divergent in its action and it may 
not influence the fatty acid transportation, it might rather act as part of a broader signaling 
network. The effect of the exercise-mimicking compound AICAR in human myotubes was 
studied by silencing BRCA1 expression using shRNA (Paper II). It was clearly 
demonstrated that AICAR induced ACC phosphorylation when BRCA1 levels were reduced 
(Paper II, Fig. 7 A and B). However, lower BRCA1 content resulted in a significant increase 
(~20 %) in basal phosphorylation of AMPK and also increased basal phosphorylation of 
ACC by ~70 %. This inactivation of ACC has previously been shown to be mediated by 
AMPK (Winder & Hardie 1996). Taken together, this suggests that BRCA1 might not be 
required but rather act as an additional player in ACC phosphorylation.  
Data from Paper II, also demonstrates that loss of BRCA1 protein (using shRNA) resulted in 
accumulation of intramyocellular lipids and reduced insulin-induced glucose uptake (Paper 
II, Fig. 5 B and D) in human myotubes. These cells also exhibited reduced Akt (protein 
kinase B) phosphorylation in response to insulin treatment compared to the insulin response 
in the control myotubes, which strengthens the notion that BRCA1 is involved in glucose 
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regulation. Apart from the glucose regulation, human myotubes with reduced BRCA1 
expression exhibited lower basal oxygen consumption rates (OCR) compared to scrambled-
shRNA myotubes (Paper II, Fig. 6 A and B). When human myotubes were treated with 
conjugated-free fatty acids, an additional increase in lipid storage in myotubes with reduced 
BRCA1 expression compared to control was observed. Also, myotubes transduced with 
shRNA-BRCA1 had higher reactive oxygen species (ROS) levels, indicating a high 
intracellular stress.  
To summarize, these data suggest that reduced BRCA1 content in human myotubes results in 
decreased insulin signaling, increased lipid storage, reduced mitochondrial function, and 
enhanced ROS production. In conclusion, the observations from Paper II provide new 
evidence for a potential role of BRCA1 as a metabolic regulator in skeletal muscle and as an 
important player in fatty acid metabolism.  
 
4.3.2 Changes in metabolic regulation following exercise in persons 
with pre-diabetes 
In Paper IV, fitness parameters and metabolic markers such as peak VO2, fasting insulin, 
HOMA-IR and HbA1c were improved significantly in the aerobic training group (Nordic 
Walking) after the intervention (Paper IV, Table. 1). Due to limited material citrate synthase 
activity (CS, a marker for mitochondrial capacity), could not be measured in the aerobic 
training group, but a trend towards increased mtDNA:nucDNA ratio (29 %) was observed. In 
the resistance group, CS activity increased significantly and there was also a trend towards an 
increase in the ratio of mtDNA:nucDNA (18 %). In contrast, the control group displayed a 
significant decrease in the ratio of mtDNA:nucDNA and a decrease (p>0.05) in CS activity 
(Paper IV, Fig. 3). This suggests that the interventions were sufficient to induce an increase 
in mitochondrial content. 
The findings presented in Paper IV, indicate that training can stimulate and might improve 
mitochondrial function. Preliminary data from study 4 show a significant increase of the 
MEF2A protein in the resistance training group. A weak correlation was detected between 
∆MEF2A and ∆HOMA-IR (as discussed in section 2.1) when pooling all intervention groups. 
Studies have showed that MEF2A can bind to the GLUT4 promoter and AICAR has been 
shown to stimulate the translocation of MEF2A to the nucleus thus affecting MEF2A 
regulation of GLUT4 (Holmes et al. 2005; Gong et al. 2011). No change in GLUT4 mRNA 
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or in the mRNA of AS160 (Akt substrate of 160 kDa, also known as TBC1D4) could be 
detected (Preliminary data from study 4). AS160 is known to be phosphorylated by AMPK 
as a response to exercise/muscle contraction (Cartee & Wojtaszewski 2007; Sakamoto & 
Holman 2008; E. A. Richter & Hargreaves 2013; Cartee 2015) and thereby initiating the 
translocation of GLUT4 to the cellular membrane. This ability makes it an interesting target 
to study in order to understand insulin-independent glucose uptake in skeletal muscle. The 
lack of mRNA change might be a result of timing as discussed in section 1.2, and reflects the 
importance of studying both the GLUT4 and the AS160 protein. In study 4, attempts to 
measure the protein of AS160 with ELISA was performed, but no absorbance differences 
compared to the blank were detected, indicating insufficient binding of the coated antibody. 
Also, the activation of AS160 in skeletal muscle seems to be highly dependent on 
phosphorylation (Cartee 2015). A regulatory stimulus, such as phosphorylation, is usually 
more of an acute way to regulate intracellular adaptations. However, an acute exercise bout in 
men has been shown to increase the levels of AS160-phosphorylation immediately after 
exercise, with levels still elevated 3 hrs after exercise (Howlett et al. 2008). In a 3-week one-
legged training study, AS160 protein levels did not increase significantly, but the 
phosphorylation of AS160 was higher both before and after insulin stimulation in the leg that 
had trained compared with the untrained leg (Frøsig et al. 2007). This indicates that the role 
of AS160 in glucose regulation and in response to exercise needs to be studied with focus on 
phosphorylation. Also that the effect might be missed in prolonged interventions, such as that 
in study 4, if an intra-individual control is not included. 
 
4.4 MITOCHONDRIAL-DERIVED PEPTIDES AFTER 
TRAINING IN PERSONS WITH PRE-DIABETICS 
Mitochondrial retrograde signaling includes communication from the mitochondria to the 
nucleus  as well as to other cellular elements (C. Lee et al. 2013). Transcription factors, such 
as PGC-1a have been identified as factors affected by mitochondrial retrograde signaling 
(Chae et al. 2013). Recently, both humanin (HN) and MOTS-c have been detected and 
described as small peptides of mitochondrial origin that could act as retrograde signals. 
Interestingly, HN levels in plasma have been implied to be lower in persons with impaired 
fasting glucose regulation in comparison to healthy controls (Voigt & Jelinek 2016). MOTS-c 
has also been shown to be important for glucose regulation by activating AMPK and GLUT 4 
in mice skeletal muscle (C. Lee et al. 2015). Furthermore, MOTS-c levels are reduced in 
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individuals suffering from obesity and in patients with insulin resistance (C. Lee et al. 2015). 
Both resistance training and endurance training are known to activate AMPK (Dreyer et al. 
2006; Lundberg, Fernandez-Gonzalo & Tesch 2014) which in turn is activated by increased 
ATP turnover and modulates cellular metabolism by phosphorylating metabolic enzymes 
(Carling & Hardie 1989; Kahn et al. 2005). Since MOTS-c has been shown to activate 
AMPK is has also been speculated that it is involved in exercise adaptation (C. Lee et al. 
2016). Furthermore, increased HN levels have been reported in conditions with oxidative 
stress such as in patients with mitochondrial encephalomyopathy suffering  from lactic 
acidosis and stroke-like episodes (MELAS) (Kariya et al. 2005). In these types of conditions, 
the mitochondrial function is impaired and the altered ATP/ADP ratio is somewhat similar to 
the intermittent alteration in cellular homeostasis seen with acute exercise. Due to the 
similarities between HN and MOTS-c it can be speculated that they might act in concert.  
 
4.4.1 Humanin expression and training 
In Paper IV, the levels of the HN protein in skeletal muscle and in serum in men with IGR 
were measured. In the resistance training group, a significant increase of the HN protein in 
skeletal muscle was observed after the intervention compared to before, and compared to 
both the aerobic (Nordic Walking) and the control group (Paper IV, Fig. 1 A). Pooling the 
data from all three groups revealed a weak correlation of HN levels and HOMA-IR. Since the 
correlation was so weak, no firm conclusion should be drawn from the statistical interaction 
between HN and HOMA-IR. However, contrary to our hypothesis, the intervention seemed 
not to elicit any changes in the HN protein levels in serum. Although, ∆HN protein levels in 
serum did correlate to the improvements in the ∆2 hrs glucose loading test in the resistance 
training group (Paper IV). This might indicate an endocrine rather than auto/paracrine effect 
of HN protein in serum. Interestingly, Muzumdar et al. have shown that injections of an HN 
analog in rats lowers blood glucose levels in a rat diabetic model (Muzumdar et al. 2009). 
The lack of change in the aerobic group (Nordic walking) could be due to the low-intensity 
rather the training type per se, something that has been discussed previously  (McGarrah et al. 
2016). Also, to bear in mind when conducting exercise interventions, mean weekly adherence 
was 1.9 and 1.8 sessions per week in the resistance and the aerobic training group 
respectively and not 3.0 as intended. Furthermore, it would be interesting to study the HN 
protein in response to training in both younger individuals and in a more demanding aerobic 
training set-up.  Even though, Paper IV could not conclude any specific improvements in the 
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prediabetes profile in skeletal muscle, previous publications based on the Nordic Walking 
study, to which study 4 belongs, have shown that markers involved in a diabetic profile 
(Venojärvi, Wasenius, et al. 2013) as well as markers for metabolic syndrome (Venojärvi, 
Korkmaz, et al. 2013) were improved with the performed intervention.  
 
4.4.2 MOTS-c expression and training 
In study 4, the protein levels of MOTS-c before and after the intervention in both skeletal 
muscle and serum from men with IGR were measured. MOTS-c protein in skeletal muscle 
showed an increase (19.5 %) in the resistance training group (p<0.05, n=15, Preliminary 
data, see Fig. 12). Serum protein levels of MOTS-c did not change over time and there was 
no difference between the groups. However, correlation analysis of the change over the 12-
weeks intervention (∆ values) revealed a negative correlation between ∆MOTS-c protein in 
serum and ∆RIP140 protein in skeletal muscle (Preliminary data, study 4, r=-0.513, 
p<0.01). Interestingly, a positive but weak correlation between of ∆MOTS-c protein in serum 
and ∆GLUT4 mRNA in skeletal muscle was detected (Preliminary data, study 4, r=0.359, 
p=0.015). This may lead to speculations that a cross-talk between of MOTS-c in serum and 
metabolic factors important for oxidative capacity in skeletal muscle might exist.  
 
 
 
Figure 12. Preliminary data; MOTS-c protein levels in human skeletal muscle (RT n= 15, NW n=11 
and CON n= 14) (A), and in serum (RT n= 14, NW n=11 and CON n= 11) (B) before and after 12-
weeks of training, study 4.  ap ≤ 0.05 with factors time x group (LMM). *p ≤ 0.05, compared to Pre 
(pairwise comparison (Sidak correction) within groups). The bars represent means ± SEM. 
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In RIP140-null mice, an increased fatty acid utilization and increased GLUT4 trafficking and 
glucose uptake in skeletal muscle have been shown (Fritah et al. 2012). RIP140 has been 
recognized as an important inhibitory player in the regulation of fat and glucose metabolism 
(Rosell et al. 2011), and T2DM patients have been observed to have higher basal levels of 
RIP140 (Xue et al. 2012). Also, in rodents RIP140 has been shown to act as a negative 
regulator of glucose uptake and to suppress expression of mitochondrial proteins (Catalán et 
al. 2009; Chen et al. 2012). Interestingly, mice treated with intraperitoneal injections of 
MOTS-c for 7 days display a significant increase in glucose clearance and improved whole-
body insulin sensitivity (C. Lee et al. 2015). The same study also found that muscles from 
older (12 months) mice were more insulin resistant than younger (3 months) mice, but that a 
7-day MOTS-c treatment restored sensitivity in the old mice to levels comparable to that in 
young animals (C. Lee et al. 2015). Also, overexpressing MOTS-c in L6-myoblasts revealed 
an accelerated glucose clearance. Further, MOTS-c treatment (72 hrs) of HEK293 cells 
increased phosphorylation of AMPK and ACC , and elevated CPT-1 protein levels, similar to 
the effects of the well-known diabetes drug metformin (C. Lee et al. 2015). However, one 
key difference between the actions of MOTS-c and metformin is that MOTS-c appears to 
directly target skeletal muscle as the key site of its activity, while metformin is thought to act 
primarily on the liver (Diamanti-Kandarakis et al. 2010; Viollet et al. 2012). Taken together, 
our findings together with earlier findings from Lee et al 2015, point toward a link between 
MOTS-c in serum and metabolic regulatory factors such as RIP140 in skeletal muscle of men 
with IGR. This makes MOTS-c a really interesting target to study further in the attempt to 
prevent metabolic diseases.  
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4.5 SUMMARY OF MAIN FINDINGS  
The results of the present thesis show that both acute and prolonged exercise training can 
induce changes in the transcription and protein machinery, mainly coupled to improved 
metabolism and mitochondrial oxidation in human skeletal muscle. The studies provide a 
comprehensive analysis of PGC-1a, the different PGC-1a transcripts and related regulatory 
network in human skeletal muscle in response to exercise. Ischemic perturbation during 
exercise enhanced activation of upstream regulatory factors coupled to PGC-1a. A one-
legged exercise model provided opportunity to study intra-individual changes of factors 
important for mitochondrial oxidation in response to acute exercise. Time-course analysis 
over 24 hours gave insights into the complex fluctuations and diurnal changes that might 
affect some of the genes and proteins involved in the acute adaptive response to exercise. 
Studying mitochondrially-encoded peptides in a population with impaired glucose regulation 
provided insights into the tentative role of the mitochondria as “exporters” of signaling 
molecules contributing to exercise adaptations.  
 
The main findings from this thesis were that; 
• acute aerobic exercise and exercise with restricted blood flow strongly affect PGC-1a 
mRNA and protein.  
• different PGC-1a transcripts exist in human skeletal muscle. 
• different PGC-1a transcripts display differences in base-line expression. 
• acute exercise rapidly increases PGC-1a-ex1b mRNA and protein levels. 
• PGC-1a-ex1b is the most exercise-responsive PGC-1a transcript. 
• full length BRCA1 and its splice variant BRCA1Δ11 and BRCA1Δ11b are detected 
in human and mouse skeletal muscle. 
• exercise seems to increase the interaction between BRCA1 and phosphorylated ACC 
both in humans and in mice. 
• there seems to be a sex difference in the BRCA1-ACCp interaction in mice. 
• high fat diet in mice upregulate BRCA1 gene expression. 
• reduced BRCA1 expression in human skeletal muscle cells results in increased lipid 
storage, decreased insulin signaling, reduced mitochondrial function and enhanced 
ROS production. 
• the basal levels and the exercise response of MaCoA is greater in female than in male 
mice. 
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• AMPK appers to be a strong candidate for exercise-induced activation of PGC-1a, 
but may not be crucial for the BRCA1 activation in skeletal muscle. 
• two LIPIN-1 (LIPIN-1a and LIPIN-1β) and three NCoR1 (NCoR1-1, NCoR1-2, and 
NCoR1-3) isoforms are present in human skeletal muscle.  
• the humanin protein, encoded from the open reading frame of the mitochondrially 
encoded 16S rRNA gene, is upregulated by resistance exercise in men with impaired 
glucose regulation, possibly in an intensity-dependent fashion.  
• MOTS-c, encoded from the open reading frame of the mitochondrially encoded 12S 
rRNA gene, seems to respond in a similar fashion to exercise as humanin. 
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4.6 GENERAL DISCUSSION 
A high oxidative capacity is important for the maintenance of health and prevention of 
disease. Skeletal muscle is highly plastic and a key player for whole body metabolism and its 
wide dynamic range of the metabolic turnover is well recognized as an important feature of a 
healthy individual.  
This thesis examines the influence of exercise on PGC-1a, a key regulator in the control of 
oxidative function. Nevertheless, the specific regulation of cell metabolism and the 
involvement of PGC-1a in aging and metabolic disorders are poorly understood. Exercise has 
been acknowledged in the same aspects as medicine in the treatment of some diseases, and 
concepts such as EIM (Exercise Is Medicine) has been established.  
The concept that exercise is beneficial for health is nothing new (Berryman 2010). Over 
2,500 years ago, a physician called Susruta prescribed exercise as a treatment for his patients. 
Documents even show that T2DM was believed to be a curable disease of the urinary tract for 
which he prescribed a certain diet and exercise. However, according to Susruta it was 
important that the exercise performed was not vigorous or with high-intensity since this was 
regarded as a risk factor for developing multiple diseases and potentially leading to death 
(Tipton 2014). Later, during the Persian empire, military leaders recognized the link between 
soldiers with good strength and endurance with the success on the battlefield. This lead to 
rigid training programs which included both strength, endurance and nutritional optimization 
(Kokkinos n.d.). And as one of the most famous exercise physicians, Hippocrates (460-370 
BCE) wrote “eating alone will not keep a man well, he must also take exercise“ (Berryman 
2010; Tipton 2014). In this perspective, exercise as prevention and treatment for common 
diseases such as T2DM is regarded as crucial, and the research field of molecular exercise 
physiology has evolved tremendously over the last decades. However, there are significant 
gaps in our understanding of the biology of exercise and its beneficial health effects and 
skeletal muscle adaptations.  
In this thesis, human exercise studies were performed in an attempt to advance the 
understanding of the regulation of the adaptations that occur following both acute and 
prolonged exercise training. By having the opportunity to study men with impaired glucose 
regulation, new insights into the connections between the mitochondria and metabolic control 
were also achieved. However, when performing human exercise studies, it is important to be 
cautious and aware of the large intra- and inter-individual variability that exists in humans, 
which sometimes can be seen as a major limitation in studying training-induced skeletal 
 86 
muscle response and adaptations. In addition, differences in genetics and epigenetics, sex 
hormonal profile, lifestyle choices as well as numerous physiological and psychological 
factors may all affect the results of the study. This is something that needs to be considered 
before any general conclusions can be drawn from the data. In study 1, an intra-individual 
control (non-exercising leg) was used, and in study 3 and 4 a control group was included. 
However, in study 2, inter-individual variations and sex differences, might have blunted some 
of the exercise effects since the number of study subjects was rather small. In study 4, the 
randomized groups were not fully homogenous, with the control group being more fit and 
also displaying lower body weight than the intervention groups. This might have influenced 
some of the comparisons made. And since the control group also was given information 
about the benefits of exercise it is quite likely that some of the included subjects were more 
active than before the intervention period. 
Human studies provide somewhat limited mechanistic insights, why they sometimes need to 
be complemented with animal models and cell studies to establish more direct mechanistic 
relationships, as done in study 1 and 2. The results from animal studies and in vitro 
experiments are commonly extrapolated to humans and there is not always an agreement 
between the results from different species (Burkhardt & Zlotnik 2013; Vandamme 2014). 
This was the case in study 2, in which the animal model showed sex differences in the 
magnitude of interaction between BRCA1 and ACC-p, as a result of the exercise stimuli but 
not in the human biopsy material. The high variability seen in the human samples may be, in 
part, due to the large degree of genetic variation in BRCA1, which can result in altered 
protein function and/or expression. The phosphorylated form of ACC interacts with BRCA1 
in the C-terminal region, specifically in the BRCT domains. Even though the BRCT domains 
in BRCA1 are well conserved across species, the BRCT domains in the human BRCA1 gene 
contain the highest degree of genetic variation (M. S. Lee et al. 2010).  
Also, conducting human exercise studies gives access to limited amount of material and 
usually mRNA analysis is conducted since it is quite straight forward and does not demand 
high quantities of material. In this thesis, the majority of the studies quantified gene 
expression changes. Gene expression changes measured as mRNA expression, are not 
necessarily synonymous with concurrent protein or functional changes. Specific mRNA 
levels do not always correlate with protein levels, although a high over all correlation has 
been suggested (Vogel & Marcotte 2012). Usually proteins exhibit a larger dynamic range of 
concentrations than transcripts do, which might mainly be due to post transcriptional 
mechanisms as well as a cumulative “stair-case” pattern of a repeatedly activated mRNA and 
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protein expressoin (Vogel et al. 2010; Perry et al. 2010). And this dynamic range is highly 
individual within humans regarding its magnitude of response.  
In animal models, the whole muscle is used for homogenized instead of a small biopsy as in 
humans. Therefore, it is also important to remember that the skeletal muscle is not a fully 
homogenous tissue. Possible differences in fiber type composition, and thereby differences in 
e.g. oxidative capacity, are present along the muscle length and at various depths (Vogel et 
al. 2010; Perry et al. 2010). Also, differences in the activation pattern and metabolism during 
exercise within the skeletal muscle fibers have been observed (Lexell et al. 1985). However, 
in all the studies conducted in this thesis, the biopsy procedure was highly standardized to 
minimize these types of errors. Nevertheless, when interpreting results from animal studies in 
the molecular exercise field, you need to remember that voluntary exercise is not always the 
case. Some exercise studies in animals apply an exercise stimulus that is more of a “life or 
death type” of situation along with substantial stress levels, which could highly influence e.g. 
the metabolic pathways aimed to be studied. Given these interspecies differences, there are 
clear advantages with human research. Furthermore, performing exercise studies may lead to 
increased understanding of skeletal muscle function and metabolism which is useful in an 
attempt to improve over-all health in humans.  
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5 CONCLUSIONS  
 
This thesis concludes that;  
• the regulation of mitochondrial adaptation following exercise is far more complex 
than previously thought as indicated by the presence and differential regulation of the 
two known PGC-1a promoters in humans skeletal muscle. 
• the PGC-1a transcripts have different roles in the adaptational process since they 
respond differently to exercise and exercise mimicking stimuli.  
• it is possible that the PGC-1a-ex1b protein is involved in the initial adaptation phase 
since it responds rapidly to exercise. 
• exercise might facilitate the mitochondrial adaptation through suppression of RIP140, 
a PGC-1a corepressor.  
• the improved fatty acid metabolism in skeletal muscle following exercise might be in 
part a consequence of increased interaction between BRCA1 and ACC-p . 
• it may be suggested that humanin has a role in glucose metabolism since it increases 
in skeletal muscle after regular resistance training in prediabetic males. 
 
  
  89 
6 FUTURE PERSPECTIVES 
The human body is made to move. Watching kids play, is sometimes like observing the very 
cornerstones of human physiology and kinetics. Historically, these movement patterns were 
key for gathering food, building tools and shelter, hunting and evading predators etc. So, 
from an evolutionary perspective, the ability to perform exercise was essential for survival. 
We are made to move, so what happens when we stop? Playgrounds are one thing, but 
consider the type of activities that are essential for survival today. What helps us survive in a 
modern technological society? 
In order to maintain health, it has been shown repeatedly that the human body needs a certain 
amount of physical activity. This need of physical activity is tightly coupled to the activation 
of gene programs that evolved during the time when we were required to be much more 
physically active than today. For many years, researchers have focused intensively on trying 
to understand the mechanisms behind training adaptation such as improved metabolic 
function and mitochondrial biogenesis. This has, in part, been done by studying how genes 
respond to training and lifestyle interventions. Despite substantial progress, significant 
knowledge gaps still remain. Thus, the mechanisms of exercise and how it affects all the cells 
in the body will most certainly continue to be of great scientific and public interest in the 
future.  
The studies in this thesis have hopefully shed new light on some of the pieces of this large 
puzzle, but more studies are obviously needed. In the future, new genetic and molecular 
techniques will further develop the scientific understanding of exercise biology. In study 4, a 
relative novel global gene expression analysis method, RNAseq, was employed to provide 
further understanding of the complex gene network activated by a certain type of training and 
how this differs between individuals. Also, we hope to see if the degree of metabolic 
dysfunction (impaired glucose regulation) might affect the outcome of the training response.  
Life is unfair, we respond differently to the same exercise stimulus which points towards the 
importance of understanding the individual response that training can cause. This will lead to 
the development of more personalized training strategies and can also improve the concept of 
exercise as medicine. Ultimately, this might lead to new strategies against several common 
diseases.  
The magic of the mitochondria is not fully understood, and the unique structure and 
functional characteristics of this organelle have raised the ideas of drugs selectively targeting 
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the mitochondria. Also, as this thesis shows, retrograde signaling molecules like 
mitochondrial-derived peptides (humanin and MOTS-c) might have more biological 
functions than shown previously. These peptides, released from the mitochondria, have 
already been linked to protective effects in some diseases such as Alzheimer’s disease and 
cancer. Exercise increases the size, number and amount of the mitochondria and increases the 
copy number of the mtDNA which might be of importance in producing more of these cyto- 
and neuro protective peptides.  
Furthermore, in the light of EIM, obese individuals and patients with diabetes are 
characterized by impaired mitochondrial function and reduced amount of mitochondria, and 
the skeletal muscle PGC-1a mRNA expression is reduced in those with diabetics. Since 
PGC-1a is important in the control of energy metabolism and insulin sensitivity, it is a highly 
interesting target for novel drugs. Exercise or specific drugs that activate PGC-1a with the 
aim to stimulate mitochondrial biogenesis should be considered for people with diabetes. 
PGC-1a has also been implicated in a novel angiogenic pathway, and results from this thesis 
may strengthen the notion that exercise-induced activation of PGC-1a might be important for 
the treatment of ischemic diseases. Collectively, further developments in the area of 
mitochondrial medicine and exercise medicine will be very important to progress in health 
and disease management.  
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 “If we could give every individual the right amount of nourishment and exercise, not too 
little and not too much, we would have found the safest way to health” 
Hippocrates, ~ 450 BC 
Kroppen är byggd för rörelse. Att röra på sig regelbundet har visats förbättra funktionen hos 
flera organ i kroppen, minska risken för sjukdomar och i vissa fall behandla sjukdom. Att 
vara fysiskt aktiv ökar t.ex. den fysiska prestationsförmågan, gör att vi sover bättre och till 
och med får fler celler i vissa områden i hjärnan som leder till att vårt minne förbättras. 
Dessutom är övervikt och diabetes betydligt mindre vanligt hos personer som motionerar. Det 
finns starka vetenskapliga bevis för att en inaktiv livsstil påverkar hälsan negativt och 
människor som är otillräckligt fysiskt aktiva lever mellan 6 och 9 år kortare än personer som 
är regelbundet aktiva.  
På detta sätt kan det vara förenat med ökad risk för förtidig död att skriva en avhandling, detta 
då personen i fråga ofta sitter enormt många timmar av sin vakna tid under skrivprocessen.  
 
7.1 VI OCH VÅRT DNA 
Människokroppen består av ca hundra tusentals miljarder enskilda celler som samverkar för 
att vi ska fungera som en organism. Grunden för människan som livsform ligger i vår kod, 
den vi kallar arvsmassan eller DNA. Denna kod är specifik och bildas då ägget och spermien 
smälter samman vid befruktningen, varvid hälften av arvsmassan kommer från ägget och 
hälften från spermien. Från denna embryonala stamcell utvecklas en mängd olika celler och 
celltyper varpå sedan vävnader, organ och till sist organsystem byggs upp vilket är det som 
utgör dig som människa. Inuti varje cell finns en cellkärna (förutom i de röda blodkropparna) 
i vilken den genetiska koden/vårt DNA finns packat. I varje cellkärna ryms ca två meter DNA 
som kodar för ca 20 000 gener dvs. avsnitt på DNA som kodar för ett visst protein. Det kan 
tyckas mycket med två meter DNA, men inte om man jämför med det japanska ormbäret som 
innehåller nästan 100 meter DNA per cellkärna. Men lugn, packningen av vårt DNA är 
optimerat så det finns gott om plats. Alla celler innehåller samma genetiska material, samma 
DNA, men ändå kan celler ha olika funktion och utseende. Detta beror på hur koden läses av, 
vilket avsnitt av koden som läses dvs. vilka gener som uttrycks i just denna cell. DNA kan ses 
som ett referensbibliotek med massa recept eller ritningar och beroende på vilket protein vi 
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vill bygga så är det ett specifikt avsnitt av DNA-molekylen som läses och varje sådant 
specifikt avsnitt är en gen. Generna uttrycks (läses och kopieras) till en molekyl som kallas 
mRNA som sedan kan översättas och veckas till ett funktionellt protein i cellerna.  
Vår yttre omgivning och inre miljö skickar signaler till cellerna om vilka proteiner som 
behövs och påverkar därmed vilken/vilka gener som skrivs av. Hur vi lever och rör på oss 
samt olika typer av sjukdomar kommer också att skicka sådana signaler till cellerna och 
påverka genuttrycket.  
Förenklat kan man säga att varje gen kodar för ett enskilt protein, och det är proteinerna som 
står för majoriteten av kroppens olika funktioner. Proteinernas funktion är t.ex. att bygga upp 
våra muskler och skapa rörelse, fungera som biologiska katalysatorer och markörer, ge våra 
celler och kroppar struktur och hållbarhet, färga vårt blod rött och bära på syremolekyler i 
blodet samt möjliggöra kommunikation inuti celler och mellan vävnader.  
I denna avhandling har jag studerat hur akut (ett enstaka träningspass) och regelbunden 
träning påverkar hur vi läser av vår kod och vilka olika mRNA molekyler som bildas samt 
om dessa bygger funktionella proteiner och om vissa proteiner ökar eller minskar som svar på 
träningen. De faktorer jag har fokuserat mest på är de som är kopplade till att öka muskelns 
aeroba anpassning och de som stimulerar cellen till att bygga fler mitokondrier (se förklaring 
nedan). 
 
7.2 SKELETTMUSKULATUREN OCH DEN MAGISKA 
MITOKONDRIEN 
I vår kropp finns tre olika typer av muskulatur; skelettmuskulatur, glatt muskulatur och 
hjärtmuskulatur. Skelettmuskulaturen är den primära vävnaden som undersökts i denna 
avhandling. Skelettmuskulaturen är ansvarig för alla våra viljemässigt styrda rörelser, vilket 
bl.a. inkluderar vårt kroppsspråk, att springa och att äta och tala. Skelettmuskulaturen har 
också förmågan att agera som en metabol vävnad vilket är viktigt för regleringen av glukos i 
blodet, blodsockret. En frisk människas kroppsvikt består till ca 40-45 % av 
skelettmuskulatur, vilket innebär att det är ett av våra största organ. Den är uppbyggd på 
liknande sätt som en rysk babushkadocka, lager på lager. Skelettmuskulaturen är uppbyggd 
av långa, tubformade celler som kallas myocyter eller muskelceller. Zoomar vi in i 
muskelcellen så ser vi att dessa ibland skiljer sig åt i funktion och utseende varpå vi kan dela 
  93 
in muskelcellerna i två huvudkategorier, långsamma (typ I) och snabba (typ IIa och typ IIx). 
Alla muskelfibrer är uppbyggda på principiellt samma sätt och består av muskelproteiner 
(aktin och myosin) som har möjlighet att glida över varandra och på så sätt 
förkorta/kontrahera en muskel. Denna process involverar kalcium och kräver energi i form 
ATP (Adenosin-Tri-Fosfat). Den minsta funktionella enheten kallas sarkomer och kan ses 
som små, små lådor innehållande våra muskelproteiner som läggs på rad i en mycket strikt 
ordning. Dessa lådor bildar sedan det vi kallar myofibrill, långa trådar av kontraherande 
enheter. Ett stort antal myofibriller buntas sedan ihop och utgör då en muskelcell. Flera 
muskelceller buntas sedan ihop och flera buntar av dessa utgör sedan själva muskulaturen (se 
Fig. 1 i avhandlingen).  
Inuti de flesta celler i vår kropp finns mycket små organeller som kallas mitokondrier. Dessa 
tros från början ha varit prokaryota celler (bakterier) som genom endocytos (upptag i annan 
cell) för ca 2 miljarder år sedan inneslöts i en eukaryotcell. Då mitokondrierna har förmåga 
att förbruka syre och bilda ATP utgjorde detta startskottet för utvecklingen av eukaryota 
organismer. Våra mitokondrier är alltås kvarlevor från en prokaryot cell och har gett oss 
förutsättningen till att bilda ATP genom nedbrytning av näringsämnen såsom kolhydrater och 
fett (genom syre krävande processer) (se Fig. 2 i avhandlingen). Mitokondrier är på så sätt 
cellens ”kraftverk”. Ett tydligt tecken på att mitokondrien är så speciell är att den har sitt eget 
DNA, så kallat mitokondriellt DNA (mtDNA). Jämfört med kärnans DNA är mtDNA mycket 
litet (endast uppbyggt av 16569 baspar jämfört med DNA som består av ca 3,3 miljarder 
baspar) och har formen av en cirkel. Skelettmuskulaturen är en av de vävnader som 
innehåller enormt många mitokondrier vilket skapar möjlighet för att kunna producera 
mycket ATP och på så sätt generera kraft och förflyttning.  Andra mitokondrierika vävnader 
är framförallt levern och hjärtat.  
 
7.3 MUSKLER, MITOKONDRIER, GENER OCH TRÄNING  
Skelettmuskulaturen anpassas efter hur vi lever, regelbunden träning gör den starkare och mer 
uthållig medan inaktivitet och stillasittande gör det motsatta. Mitokondrier påverkas också 
mycket av hur vi lever och av träning. Särskilt uthållighetsträning signalerar till kroppens 
vävnader såsom skelettmuskulaturen att fler mitokondrier ska byggas, så kallad mitokondriell 
biogenes. Träning gör att mitokondrierna blir fler och effektivare på att förbränna 
näringsämnen och syre, samt att bilda energi. Även om mitokondrien har sin egen genetiska 
kod så är den i behov av signaler/proteiner från kärnans kod för att kunna läsa av och kopiera 
sitt mtDNA.  
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Det finns otaliga studier som visar att träning, både akut och regelbunden, förändrar vilka 
gener i vårt DNA som skrivs av. Detta leder i slutänden till de anpassningar vår kropp 
åstadkommer som svar på träning vare sig det handlar om att bilda fler blodkärl, fler 
mitokondrier, fler muskelproteiner eller göra vårt hjärta starkare.  
 
7.4 MUSKELBIOPSIER OCH MOLEKYLÄRA METODER 
För att kunna studera vad som händer i skelettmuskulaturen på genetisk nivå så har vi i denna 
avhandling tagit muskelprover, så kallade muskelbiopsier, från våra frivilliga 
försökspersoner. Dessa biopsier kan i storlek jämföras med ett tjockt riskorn och väger ca 100 
mg, vilket är en relativt försumbar bit räknat till lårmuskulaturens totala storlek. I korthet går 
proceduren till som följer; huden lokalbedövas, ett litet snitt görs genom huden och ner till 
muskelns yttre hinna, muskelfascian. Biopsinålen förs därefter ner genom snittet och in i 
muskeln. Biopsinålen kan liknas vid en giljotin, muskeln sugs in i en liten öppning i nålen för 
att sedan kapas av. Samtliga muskelprover i denna avhandling har tagits från den yttre av 
lårmuskelaturens fyra delar, musculus vastus lateralis.  
Då skelettmuskulaturen är en sådan fantastisk vävnad att studera och har en enorm förmåga 
till anpassning så möjliggör det att vi även kunnat ta upprepade biopsier från samma person. 
Detta har gjort att vi kunnat studera de genetiska och mitokondriella förändringar som sker 
över tid med träning. För att studera detta så har molekylära analyser gjorts i vårt 
laboratorium, med en kombination av kemi, molekylärbiologi och modern teknik där DNA, 
mtDNA, mRNA och specifika protein kunnat isoleras från muskelproverna för analys. Celler 
som isolerats från muskelproverna har också odlats för att kunna studera hur olika tillsatta 
ämnen påverkar vissa gen- och proteinuttryck. 
Utöver muskelprover har även blodprover tagits samt fysiologiska tester utförts på 
försökspersonerna såsom t.ex. max-prestationstest på cykel och test av muskelstyrka och 
explosivitet. 
 
7.5 VAD VISADE EGENTLIGEN AVHANDLINGEN? 
I denna avhandling har fyra olika träningsstudier genomförts (se Tabell.1 i avhandlingen). En 
kortfattad sammanfattning av de viktigaste resultaten följer nedan. 
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I studie 1 har träning med reducerat blodflöde till muskeln använts (genom att träna ena benet 
i en tryckkammare) för att studera hur ischemisk träning (nedsatt blodflöde som leder till bl.a 
mindre syretillgång) påverkar träningssvaret i skelettmuskulaturen efter 45 minuters enbens-
sparks träning (ena benet tränade med ischemi och det andra utan). I studie 2 och 3 har 
försökspersonerna cyklat i 60 minuter, och i studie 2 användes en translationell försöksdesign 
vilket innebar att även möss tränades. I studie 4 genomfördes 12 veckors träning med tre 
grupper av män med nedsatt glukosreglering, så kallade pre-diabetiker. Dessa män delades 
slumpmässigt in i grupper och tränade antingen styrketräning eller stavgång alternativt ingick 
i en kontrollgrupp. Samtliga studier i denna avhandling studerar hur träningen påverkade 
olika gener och proteiner kopplade till mitokondriell biogenes med främst fokus på ett protein 
som heter Peroxisome proliferator-activated receptor (PPAR)-g coactivator (PGC)-1α som vi 
kallar PGC-1α.  
Resultat från studie 1 visar att ischemisk träning påverkar både gen- och proteinuttrycket mer 
än traditionell konditionsträning. Vi kunde också för första gången hos människa visa att det 
finns isoformer (varianter) av PGC-1α som skrevs av från andra promotorer (avsnitt på  DNA 
som reglerar gener uttryck), dessa kallas PGC-1α-ex1a och PGC-1α-ex1b. Vi kunde med 
cellförsök också se att en av dessa PGC-1α varianter, nämligen PGC-1α-ex1b är den som 
svarar mest och snabbast på träning. Analyser gjordes både i homogenat och från odlade 
celler från muskelproverna. I studie 2 undersökte vi hur akut cykelträning (försökspersoner) 
eller löpning (möss) påverkade ett protein som heter breast cancer 1 early onset (BRCA1), 
sedan tidigare mest känd inom bröstcancerområdet. Vi ville se hur detta östrogenkänsliga 
protein är kopplat till fettmetabolismen och mitokondriell funktion. I denna studie kunde vi i 
möss se att BRCA1 uttrycks olika i olika typer av muskler samt att uttrycket skiljer sig 
mellan könen. I människa kunde vi se att träning påverkar och ökar interaktionen av BRCA1 
med fosforylerat acetyl coenzym A carboxylas (ACC-p) vilket ökade fettmetabolismen och är 
kopplat till förbättrad mitokondriell funktion samt ökad insulinkänslighet.  
I studie 3 ville vi studera hur PGC-1α och dess olika isoformer (fem olika varianter) 
påverkades av ett enstaka träningspass samt ett nätverk av faktorer kopplade till PGC-1α och 
mitokondriell biogenes. Vi ville också studera hur gen- och proteinuttryck förändrades som 
svar på träning över 24 timmar. Detta gjorde vi genom att ta upprepade biopsier (5 st) i en 
grupp som randomiserats till träning och en grupp som inte tränade (kontroller). I denna 
studie kunde vi återigen se att PGC-1α-ex1b isoformen är den mest träningskänsliga av PGC-
1α varianterna och att den verkar vara inblandad i det initiala adaptationssvaret som sker efter 
ett enstaka träningspass. Vi kunde också se att vissa genuttryck som tidigare vetenskapliga 
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studier föreslagit som ”tränings-gener” egentligen var aktiverade som en följd av själva 
biopsitagningen.  
I studie 4 ville vi studera hur olika typer av träning (styrketräning eller stavgång) påverkar 
muskulaturens metabolism och reglering av glukos hos män i åldern 40-65 år. I denna studie 
visar vi också att mtDNA verkar kunna producera två egna proteiner som kodats från det lilla 
mtDNAt. Dessa proteiner har inte helt kartlagda funktioner men troligtvis är de kopplade till 
insulinkänslighet, åldrande och innehar cellskyddande egenskaper och har setts påverka 
miljön utanför mitokondrien. Dessa proteiner heter humanin och MOTS-c och verkar kunna 
skrivas av och öka i proteinmängd med främst styrketräning. Dessa mitokondriellt kodade 
proteiner kan vara viktiga för den förbättring som ses av glukosregleringen med träning, men 
har också visats skydda nervvävnad och motverka delningen av cancerceller, och kan därför 
vara viktiga i syfte att minska risken för att drabbas av typ 2 diabetes eller andra sjukdomar 
såsom Alzheimers och cancer.  
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